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Abstract 
 
Psychological stress is common and contributes to many physical and 
mental health problems. Its effects are mediated by a complex neurobiological 
system centering in the brain with effectors including autonomic nervous system, 
hypothalamic-pituitary-adrenal axis, inflammatory system, and gene expression. 
A stressor pushes the human physiological system away from its baseline state 
towards a lower utility state. The physiological system may return towards the 
original state but may be shifted to a lower utility state.  While some physiological 
changes induced by stressors may benefit health, chronic stressors usually have 
negative effects on health. In contrast to this stressor effect is the system’s 
resilience which influences its ability to return to the high utility attractor basin 
following a perturbation by increasing the likelihood and/or speed of returning to 
the baseline state following a stressor.  
Age-related cognitive decline is a major public health issue with few 
preventative options. Stress contributes to this cognitive decline, and mindfulness 
meditation (MM) is a behavioral intervention that reduces stress and stress 
reactivity in many health conditions. A randomized clinical trial was performed to 
determine if MM in older adults would improve measures of cognitive function, as 
well as psychology and physiology, and to determine what factors might predict 
who would improve. 134 at least mildly stressed 50-85 year olds were 
randomized to a MM intervention or a wait-list control. Outcome measures 
included a broad cognitive function battery with emphasis on attention and 
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executive function, self-rated psychological measures of affect and stress, and 
physiological measures of stress. Self-rated measures related to negative affect 
and stress were all significantly improved as a result of the MM intervention 
compared to wait-list control. There were no changes in cognition, salivary 
cortisol, and heart rate variability. Potential explanations for the discrepancy 
between the beneficial mental health outcomes and lack of impact on cognitive 
and physiological outcomes are discussed. 
To determine which factors predict MM responsiveness, a responder was 
defined by determining if there was a minimum clinically important improvement 
in mental health. Predictors included demographic information and selected self-
rated baseline measures related to stress and affect. Classification was 
performed using decision tree analysis. There were 61 responders and 60 non-
responders. Univariate statistical analysis of the baseline measures 
demonstrated significant differences between the responder and non-responders 
in several self-rated mental health measures. However, decision tree was unable 
to achieve a reliable classification rate better than 65%.  
A number of future research directions were suggested by this study 
,including to optimize the MM intervention itself, to better select participants who 
would benefit from MM, and to improve the outcome measures perhaps by 
focusing on decreased reactivity to stressful events.  Finally, a less well-defined 
but always present future research direction is the development of better models 
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and better quantitative analysis approaches to the multivariate but dynamically 
limited human empirical data that can be practically collected.  
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Chapter 1.  
Introduction    
The motivation for this research is to be able to better evaluate the effect of a 
stress-reducing therapy, mindfulness meditation (MM), in a group of older adults.  
The relationship between age-related cognitive changes and stress, and the 
remediation of those cognitive changes with a stress-reducing intervention, MM, 
is the focus of the research analyses of this dissertation. Chapter 1 provides a 
focused background for the research and some details about the data that will be 
analyzed in chapters 3 and 4. Chapter 2 consists of a more complete review and 
synthesis of the literature concerning a systems approach to stress and 
resilience in humans based on a just-published paper by the candidate. Chapters 
3 and 4 are papers that utilize specific analytic techniques to analyze data that 
were obtained over the last 5 years as outlined in chapter 1. Chapter 5 is a 
synthesis and discussion chapter. Some text in the introduction/background and 
methods sections in Chapters 3 and 4 are repetitions but are important to ensure 
the chapters can stand-alone for journal publication.  
 
Age-related cognitive decline is prevalent with significant cost to society 
and very limited preventions.  The prevalence of cognitive decline associated 
with functional impairment, dementia, is about 14% of Americans over 71 years 
old.[1] The cost to the US is around $200 billion.[2] Cognitive impairment without 
dementia in those over 71 is even more prevalent, about 22%.[3] Despite the 
personal and societal cost and known epidemiological risk factors such as 
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hypertension or low education, there are no evidence-based recommendations 
for prevention of age-related cognitive decline.[4] There is an urgent need to 
develop prevention strategies extending beyond pharmacological and dietary 
supplement approaches. Mildly improving cognition and delaying the onset of 
dementia by 6 months with a widely available behavioral intervention would 
decrease the number of dementia cases by over 100,000 over a 10-year 
period.[5] 
 
Older adults are more likely to develop cognitive symptoms from medical 
conditions. In addition to slowly progressive cognitive decline, older adults are 
much more likely to develop significant but transient cognitive impairments even 
to the point of delirium. Overall brain function weakening could be caused by 
depression, nutritional defects, oral or anesthetic medications with central 
nervous system effects, or simple hospitalization.[6-8] This highlights that older 
adults are more susceptible than younger adults to any process that negatively 
affects brain function. Developing strategies to decrease the negative impact of 
depression and stress contributing to age-related cognitive decline is the 
rationale for this research.  
 
Psychological stress is very common and contributes to health problems. 
25% of surveyed American adults reported high stress and 50% reported a major 
stressful event over the past year according to a 2014 survey.[9] While health 
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problems contributed to stress, mundane daily activities also contributed. The top 
three were juggling family schedules, hearing about what the government or 
politicians are doing, and reading or listening to the news. Stress is caused by 
any event with Novelty, Unexpectedness, Threat to ego, or Sense of not being in 
control (NUTS).[10] Stress directly costs society through decreased work 
productivity and increased sick days. Chronic psychological stress also affects 
the underlying pathophysiology or stress-related symptoms contributing to a 
broad range of diseases such as cardiovascular health,[11-14] neurologic and 
psychiatric diseases such as epilepsy,[15] Parkinson's disease,[16-18] multiple 
sclerosis,[19, 20] eating disorders, and addictions.[21] Stress may also worsen 
behavioral symptoms such as anger and thus, may symptomatically worsen 
disorders such as traumatic brain injury, Post-Traumatic Stress Disorder (PTSD) 
and dementia. Therefore, evidence-based approaches that reduce psychological 
stress will improve population health. 
 
Psychological stress and reactivity to stress contributes to age-related 
cognitive decline. Not only does psychological health affect general health, it 
also affects brain health specifically. Chronic psychological stress contributes to 
cognitive decline, hippocampal injury, and neurodegenerative diseases either 
directly or through stress mediators.[14, 22-27]. The negative effect of 
psychological stress on cognitive function may be greater with aging [28-31]. 
Higher reactivity to negative events produces physiological changes.[32] In fact, 
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negative reactions to events are more predictive of emotional well-being than the 
event itself.[33] Neuroticism, i.e., elevated stress reactivity associated with 
negative emotions, has genetic, neurobiological, and environmental 
contributions.[30, 34, 35] High neuroticism contributes to many health 
disorders[36] and is linked to increased age-related cognitive change and clinical 
Alzheimer disease (AD) in longitudinal studies (although the neuropathology of 
this cognitive change or clinical dementia syndrome is not related to amyloid 
deposition).[37-39]  The cognitive deficits related to proneness to distress are not 
specific and most consistently include frontal-executive function and perceptual 
speed,[37, 39] similar to cognitive changes associated with affective disorders 
such as PTSD and depression.[40, 41] Neuroticism with its negative effects on 
cognition is a modifiable risk factor[42] with a potentially large impact on 
population health.[43]  
 
Resilience to stress can be protective and can be learned. While high 
reactivity to stress can be detrimental to one’s health, resilience to stressors can 
be protective. Resilience is the ability an individual’s physiology and psychology 
to avoid a diseased/disordered state and/or to return to a baseline state more 
quickly following a stressor. Resilience has been used quantitatively in systems 
science for decades.[44] However, the adaptive neuroplastic responses 
underlying human resilience are just beginning to be understood from the 
neurobiology perspective.[45] Depression and stress produce increases in 
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amygdala reactivity and size and decreases in hippocampal and frontal cortex 
size; resilience to stress might be a marker for neuroplasticity associated with 
interventions such as meditation training.[41, 46] Individuals respond differently 
to similar negative stressors. Resilience to psychological stress is associated 
with no prior history of depression, male gender, lower neuroticism, and high self-
esteem and results in decreased incidence of significant psychopathology, such 
as PTSD or major depression, when exposed to a stressor.[47-50] Similar 
protective characteristics such as self-efficacy, personal mastery, and coping, are 
associated with resilience to the stress of dementia caregiving.[51]   
     Aspects of resilience are also important for minimizing cognitive decline but 
this has been underexplored from both the intervention and neurobiology 
perspective. Applying the definition of resilience to AD, we could call the brain 
insult or stressor AD pathology and the disordered state, dementia. Thus, 
resilience to AD pathology can be demonstrated by similar amounts of AD 
pathology producing variable cognitive decline. Characteristics of resilience to 
the AD pathology could include cognitive reserve,[52] larger brain or 
hippocampal size,[53] compensatory ability while performing cognitive tasks,[54] 
lesser amounts of co-existing white matter pathology associated with 
cerebrovascular pathology,[55, 56] or preservation of neuron numbers, synaptic 
markers and axonal geometry.[57] Any intervention that could improve resilience 
to stress may favorably influence cognitive decline. While psychophysiological 
resilience to laboratory stressors has been widely used, e.g.,[58, 59] the 
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experimental reactivity to stressors has not been as widely evaluated using 
fMRI.[60-64]  
     Low doses of a stressor may improve the resilience of the physiological 
system[65, 66] Exposure to low doses of stressors reduces stress reactivity, 
whether the stressor is exercise[67] or caloric restriction.[68] Psychophysiological 
and cortisol responses to stress have been altered by cognitive behavioral 
therapy[69] and stress management programs.[70] Decreased prefrontal control 
of emotional reactivity is present in depression and can be altered by cognitive 
behavioral therapy[40]  and meditation (see below).  
 
Mindfulness Meditation (MM) interventions may support cognitive function 
in older adults and reduce reactivity to stress and increase resilience. A 
behavioral intervention such as meditation that could reduce reactivity to stress 
and increase resilience in older adults may improve cognitive decline and thus 
reduce overall health costs and burden in the US. Mind-body medicine, such as 
meditation and yoga, is the most commonly used type of complementary and 
alternative medicine treatment[71] and it attempts to modify individuals’ stress 
responses.[72, 73] A recent NIH survey shows that more than 20 million U.S. 
adults practice meditation for health. While meditation practices have different 
areas of emphasis,[74] MM shows promise in many health conditions.  MM is 
popular and teaches skills applicable to everyday life situations.[74] A key facet 
of MM is attending to the present moment in a non-judgmental way. MM 
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intervention has already been formally studied and applied in a variety of clinical 
conditions including PTSD, depression, pain, and stress.[75-85] 
 
Meditation decreases negative affect and increases positive affect and 
resilience. MM is an acceptable and evidence-based treatment for stress and 
depression.[86, 87] Mindfulness has several components.[88, 89] The non-
judgmental component or not reacting overly emotionally to external or internal 
events is an important aspect of MM training and is directly related to negative 
affect. We have found this non-judgmental component to differ in those with 
chronic stress, i.e., veterans with compared to veterans without PTSD,[90] and 
older adults who are dementia caregivers compared to age-matched non-
caregivers.[30] Positive affect, which is not simply the opposite of negative affect, 
may be also improved by meditation.[46, 91, 92] Meditation also decreases 
reactivity to computer game stressors,[93] Trier Social Stress Test,[94, 95] and a 
film stressor[96] in younger adults.  
 
Meditation is associated with improved cognitive function. Most cognitive 
and neuroimaging meditation studies have been uncontrolled or cross-sectional 
(comparing experienced to beginner meditators or non-meditators).[97] The 
cognitive outcome studies with younger adults and RCTs are limited.[98-105] 
Regardless, attention and executive function improvement has been suggested. 
A recent systematic review of meditation effects on age-related cognitive decline 
8 
 
in older adults[106] found only 6 studies including an earlier study of the 
candidate’s, a dementia caregiver study.[107] The improvements on clinical 
neuropsychological tests observed in these studies were usually in the frontal-
executive function domain, such as the Stroop task where participants report the 
color in which a color-word is written and not simply read the color-word (“blue” 
written in red ink should be reported as “red” and not “blue”) [108] and Trails 
where participants alternate connecting by pencil sequential letters and numbers 
but alternating them (A – 1 – B – 2 – C – 3 …). Meditation likely produces its 
cognitive benefits through two mechanisms: 1) improving cognition by decreasing 
levels of stress and/or stress reactivity or 2) improving attention through attention 
training. (These two mechanisms are not mutually exclusive.) While meditation 
holds promise for improving cognitive function more research is needed. We will 
focus on meditation reducing stress and improving resilience for improving 
cognition in older adults.  
 
Meditation has produced changes in neuroimaging: structural and 
functional MRI in younger adults. As noted above with cognitive function, most 
meditation structural neuroimaging research consists of cross-sectional or 
uncontrolled pre- and post-meditation training comparisons.[109] As with 
structural imaging, few RCTs evaluate physiological changes of meditation using 
either EEG, event-related potentials or fMRI.[110-112]  
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Who benefits from meditation? Despite reported improvements following 
meditation interventions, there has been little research into who benefits from 
meditation. Given the complexity of the stress system including its interaction 
with much of human physiology, it would be helpful to know what factors might 
predict clinically significant improvements from meditation since it likely that 
some people benefit significantly while others may not benefit at all. At least 
some measures of affect impact on response to meditation treatment. People 
with panic disorder receiving mindfulness-based cognitive therapy demonstrated 
greater improvements in their panic disorder symptoms if they were less 
depressed at baseline based on Hamilton Depression Rating Scale. [113] Since 
regression to the mean is one confound when determining responsiveness to 
treatment, in part explaining some reported placebo effects[114], the fact that the 
less depressed people responding more suggests an alternative explanation. 
 
Summary of background and rationale for research. There is evidence that 
excessive stress causes cognitive and brain changes and that meditation 
practice can reduce levels of stress. There is less evidence that meditation 
reduces physiological stress reactivity and very limited evidence that meditation 
may improve cognitive function in older adults. It is not known whether the 
cognitive function of older adults can be improved with meditation and this is of 
very high significance, even if the improvement is only moderate. It is also not 
known how reactivity to stress contributes to cognitive change. Understanding 
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how stress contributes to cognitive change and how decreased stress might 
improve cognition would be of high significance to guide strategies that maximize 
cognitive health in aging.  From a Systems Science perspective, there are many 
interacting variables measured over time with unclear relationships. It is 
important to utilize analysis methodologies that can capture as much of the 
dynamic aspects of the data as possible. 
 
Data collection for this dissertation was done under the direction of the candidate 
while he was enrolled in the Portland State University Systems Science PhD 
program. Two research assistants working directly under the candidate’s 
supervision collected the data and another research assistant provided the MM 
training intervention. There was no external funding for this particular research 
project although the candidate’s NIH K24 award for career development provided 
some salary support for the candidate and 50% salary support for a single 
research assistant. 
 
METHODOLOGY  
Participants consisted of generally healthy adults 50-75 years of age who 
reported at least mild stress. Further inclusion and exclusion criteria as well as 
recruitment information are provided in chapter 3. 
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Figure 1.1. Schematic of participant visits and study flow 
 
There were three testing visits (Figure 1.1), each 2 months apart, and 
participants received a 6-week mindfulness meditation (MM) intervention either 
between Visits 1 and 2 or between Visits 2 and 3. Participants who received the 
intervention directly after Visit 1 were encouraged to continue meditating 
between Visits 2 and 3, and participants who received the intervention post-Visit 
2 served as a wait-list control. The outcome measures include: 1) self-rated 
measures of stress and affect; 2) measures of cognitive function, and; 3) 
physiological markers of stress. Further information regarding the rationale and 
the specific measures are provided in chapters 3 and 4. Several self-rated 
stress/affect measures and a single cognitive function measure were obtained at 
each visit using ecological momentary assessment (EMA) that made 
assessments using a smartphone at four time points over a 24-hour period 
excluding sleep times at the time of each visit while the participants were in their 
usual environment. 
Intervention  
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The MM intervention was administered in six, one-on-one sessions occurring 
weekly either between visit 1 and visit 2, or between visit 2 and visit 3 (wait-list 
control). The intervention also involved recommended daily home-practice. An 
unblinded RA delivered the training sessions but the assessments were 
performed by blinded RAs. Having only a wait-list control implies that some 
benefit of the MM compared to wait-list may be related to placebo effects [115] 
but this study was done with limited funding. Below is a brief description of the 
MM intervention and wait-list control condition. Participants who were 
randomized to the wait-list arm between visit 1 and visit 2 received the MM 
intervention after the wait-list period (between visit 2 and visit 3). Adherence for 
the MM intervention was assessed using a study iPod.[116]. All participants met 
weekly with the unblinded RA during the active 2-month intervention block and at 
the halfway point in the other 2-month block to help minimize drop-outs.  
 
Assessments (Table 1.1) 
Outcome assessments were done at each visit. More details are given in Chapter 
3. 
 
Table 1.1. Assessments at the three visits 
           Assessments Visit 1  
(baseline) 
Visit 2  
(2 
months)  
Visit 3 
(4 
months) 
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Cognitive assessments X X X 
Other physiological measures (EEG, ECG, 
bp, respiration rate, cortisol) 
X X X 
Questionnaires: e.g., stress, neuroticism, 
mood, fatigue, mindfulness, & resilience 
X X X 
Smartphone ecological momentary 
assessment  
X X X 
Adherence (paper log and study iPod)  X X 
Expectancy/Credibility   X   
 
Cognitive Assessments were based on prior studies and focused on 
frontal/executive function but also included episodic memory, working memory, 
and reaction time.  At all visits, participants were assessed with self-rated 
measures that might interact with or mediate the MM intervention effect, including 
stress, neuroticism, mood, fatigue, self-efficacy, sleep quality, mindfulness, 
resilience. Physiological assessments include EEG, heart rate and heart rate 
variability, and salivary cortisol. Expectancy and Credibility assessments were 
performed to determine if expectancy impacted any improvements observed from 
the MM intervention.    
The next chapter expands on this Introduction to focus on the human stress 
system trying to integrate knowledge of the physiology of the stress system with 
knowledge from systems science.  
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Chapter 2 
A systems approach to stress, stressors and resilience in hhumans 
Published in Behavioural Brain Research 2015, 282:144-154, authors B.S. Oken, 
I. Chamine, and W. Wakeland  
  
Abstract: 
The paper focuses on the biology of stress and resilience and their biomarkers in 
humans from the system science perspective. A stressor pushes the 
physiological system away from its baseline state towards a lower utility state. 
The physiological system may return towards the original state in one attractor 
basin but may be shifted to a state in another, lower utility attractor basin.  While 
some physiological changes induced by stressors may benefit health, there is 
often a chronic wear and tear cost due to implementing changes to enable the 
return of the system to its baseline state and maintain itself in the high utility 
baseline attractor basin following repeated perturbations. This cost, also called 
allostatic load, is the utility reduction associated with both a change in state and 
with alterations in the attractor basin that affect system responses following 
future perturbations. This added cost can increase the time course of the return 
to baseline or the likelihood of moving into a different attractor basin following a 
perturbation. Opposite to this is the system’s resilience which influences its ability 
to return to the high utility attractor basin following a perturbation by increasing 
the likelihood and/or speed of returning to the baseline state following a stressor. 
This review paper is a qualitative systematic review; it covers areas most 
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relevant for moving the stress and resilience field forward from a more 
quantitative and neuroscientific perspective. 
Keywords: psychological stress, systems science, allostatic load, resilience 
Abbreviations 
ACTH: adrenocorticotrophic hormone  
ANS: autonomic nervous system  
DHEA: dehydroepiandrosterone 
DHEAS: dehydroepiandrosterone sulfate 
EEG: electroencephalogram 
fMRI: functional magnetic resonance imaging 
HgbA1c:  glycosylated hemoglobin A1c 
HPA axis: hypothalamo-pituitary-adrenal axis 
HRV: heart rate variability  
PET: positron emission tomography 
 PTSD: post-traumatic stress disorder  
SSRI: selective serotonin reuptake inhibitor  
1. Introduction 
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Psychological stress is common in our society. A recent survey indicated that 
25% of Americans reported high stress and 50% identified a major stressful 
event during the previous year [9]. Chronic psychological stress increases risk of 
health problems and contributes to cardiovascular problems [11, 117], neurologic 
and psychiatric diseases such as epilepsy [118], Parkinson's disease [17], 
multiple sclerosis [19], eating disorders, addictions [21], post-traumatic stress 
disorder (PTSD), and sleep difficulties. Therefore, it is important to develop 
evidence-based methods that minimize stress impact. A fuller understanding of 
stress physiology and psychology can be achieved by approaching this topic 
from different angles. This work offers a review of stress physiology and 
psychology from a systems science perspective. 
 
Systems science is a methodology used to understand complex systems from 
organizational, structural, and dynamic perspectives.[119] From a systems 
science viewpoint, stress often corresponds to a state away from optimal in a 
dynamical system where the optimal location represents a high utility attractor. 
An attractor basin in a dynamical system corresponds to the conceptual space of 
locations in which the system resides over time. The state of stress results from a 
perturbation arising from the internal or external environment (stressor). This 
stressor could result in the system returning to the baseline optimal attractor or 
moving into a lower utility attractor basin. The attractor basin is the region of 
space that shares the same attractor and the whole space may have multiple 
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attractors (Figure 2.1).   
 
The attractor in the human system is not a fixed point attractor given the 
multidimensional nature and, almost inherent, within-subject temporal variability 
of the physiological measures of state. The noise present in the measurement of 
the many variables constituting the human system implies the observed human 
system is stochastic; thus, the attractors are very difficult to describe. In addition, 
given the varying time frames over which the components of the human 
physiological system change, the terms state and variable describing more 
immediate changes and the terms trait or parameter describing longer time frame 
changes represent an artificial separation of the various physiological measures 
that have different units and widely distributed half-lives. Whatever the attractor, 
even if the system returns to the baseline high utility attractor, there is often some 
underlying cost. This cost to the system is a change in the underlying physiology 
that may: 1) decrease the rate of return to the high utility attractor or 2) decrease 
the likelihood of returning to the optimal attractor following a future stressor 
perturbation because the size of the attractor basin is smaller or the attractor has 
moved closer to a boundary with a non-optimal attractor basin. The movement of 
the dynamical system into a different attractor basin could also be due to a single 
severe stressor potentially via a dynamical system catastrophe, for example, 
development of PTSD following a single event (Figure 2.2).  
18 
 
 
Besides negative effects, the stressor can also induce beneficial changes leaving 
the system more resilient to future perturbations, i.e., cause the opposite of 1) 
and 2) above. The term resilience includes several conceptual aspects. 
Resilience refers to how effectively and quickly the system returns to 
baseline.[44] This includes whether the human dynamical system avoids moving 
to a lower utility disease state following a stressor.[45] A related term is stability 
which refers to how well the system can maintain its current high utility condition 
without being pushed away.  
 
Although a stressor may cause a short-term decrease in some measure of utility, 
sometimes it results in longer-term utility increase. In the case of humans, this is 
related to learning as discussed below. The human dynamical system may 
experience some low-stress environmental perturbation that results in a relatively 
immediate gain in reward or utility, e.g., obtaining food when hungry or some 
longer-term gain in utility, e.g., the brain acquiring a better understanding of the 
environment. There is an apparent inverted u-shaped effect of stress on longer-
term utility, such that occasional small amounts of stress may improve both 
short- and long-term utility but experiencing no stress or large amounts of stress 
may have negative long-term effects on the organism. Though the term “human” 
will be used, most of this discussion applies to other animals and to systems in 
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general.  
 
2. The human physiologic system: brain structure and network (Figure 
2.3) 
A human is a dynamical system composed of subsystems that help maximize 
utility of the organism. Utility may be defined: 1) from a purely biological 
perspective such as immediate reproductive success or obtaining food, or 2) 
from a more complex, perhaps hedonic or longer-term perspective such as 
longer-term reproductive success, obtaining more resources, gaining group 
support or enjoying an amusement park ride. Longer-term utility could extend 
beyond the lifespan, e.g., survival of the related social unit or the entire species 
(see section 9 for more information about utility). The organism is maintained by 
many critical systems and subsystems, such as cardiovascular and renal, but this 
paper focuses on the brain dynamical system and its communication links with 
the body via autonomic nervous system (ANS), hypothalamo-pituitary-adrenal 
(HPA) axis and neuroimmune system. The limbic system is involved in 
psychological aspects of stress, including neocortex activation by emotional 
states and memories of events associated with emotional valences. Older and 
more caudal brain parts including the brainstem and spinal cord are generally not 
critical for the following discussion with some exceptions including ANS 
components. The sympathetic portion of the ANS involving central 
catecholaminergic systems is particularly important for communicating the brain 
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perception of stress to the whole body by causing changes such as increased 
blood pressure and heart rate. The hypothalamus is an important communication 
link secreting neurohormones, e.g., adrenocorticotrophic hormone (ACTH). 
Given this background, the most commonly discussed physiologic responses to a 
stressor involve the HPA axis, the locus coeruleus-norepinephrine-sympathetic 
nervous system pathway, the parasympathetic system, the immune system, and 
gene expression and alterations including epigenetic changes.  
 
The two-way communication between the major effector systems (ANS, HPA, 
and immune) and the brain exist in part to ensure the stress-related systems 
provide feedback for learning and help avoid over-reactivity. The communication 
system between the immune system and the brain constitutes an entire field 
itself, psychoneuroimmunology.[120] The immune system - brain communication 
is significantly mediated by cytokines. All these two-way communication systems 
directly impact the brain via its receptors for norepinephrine, ACTH, cortisol, and 
cytokines, with prefrontal cortex, hippocampus, and amygdala being most 
prominent.[121] Feedback is often inhibitory and is not perfect. Occasional errors 
in this two-way communication system may arise. For example, a major increase 
in heart rate in an exercising older adult with atherosclerosis might be 
accompanied by an attempt to decrease the heart rate, but this decrease may be 
insufficient to prevent a myocardial infarction and even a sudden death.[122] 
Additionally, the awareness of stress may itself be a stressor; however, this type 
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of stress is distinct from experiencing external environmental stressors. Stress 
awareness may be commonly related to the “recall” or association of particular 
environmental inputs with prior stress. 
 
3. Stressor 
A stressor is an environmental event that significantly perturbs the entire human 
dynamical system away from the optimal attractor resulting in a state of lower 
utility.  The stressor may move the physiological system to a different attractor 
basin, move the system state closer to the edge between its current attractor 
basin and another attractor basin of the physiological system (“precariousness”), 
or slow the rate at which the system returns to the optimal attractor. The 
movement of the system is not dependent solely on objective measures of the 
stressor but also on the individuals’ traits of distress proneness and their 
perceptions of the stressor. If the perturbation is perceived to impact an organism 
negatively or associated with obvious threats (hunger/visualization of aggressor), 
there is an immediate effect to reduce the likelihood of a negative stressor 
impact. For example, seeing a bear with her cub while hiking will generate 
physiological changes important for action (elevated heart rate and blood 
pressure) and increased attention to environmental stimuli, thus improving 
encoding of the situation for future recollection. These perturbations increase 
likelihood of survival over the short-term but if maintained long-term may have 
deleterious effects. For example, a transient increase in blood pressure is 
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tolerable and may be helpful, but a chronic increase in blood pressure is not high 
utility. Stress doses that are not high enough to cause significant health problems 
such as disease or death from a state change may produce higher average utility 
within the basin by altering the shape of the basin or by moving to a different, 
higher utility basin. In an athletics example, both short-term stress at an Olympic 
competition and longer-term stress from high effort athletic activity over a training 
period may improve athletic performance.  However, excessive or repeated 
perturbations may have a cost to the underlying system that outweighs the 
benefit. 
 
Stressors may include external environment perturbations such as extreme heat 
or icy roads while driving. Stressors may also include internal environment 
perturbations such as infections or elevated glucose. Stressors may be 
predominantly psychological and mediated by brain perception and future 
expectancy. Stressors are not necessarily physical changes in the environment 
but may involve loss of a significant relationship, financial stress, negative 
neighborhood characteristics, or social threats including discrimination [123-126].  
 
For most of this discussion, the stressor referring to perturbations under tight 
physiological control will be omitted. Information signals from these perturbations 
such as alterations in serum sodium do not need to reach the brain level to be 
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regulated. Homeostasis refers to the dynamic control of these state variables 
maintained within a narrow window for humans to successfully function. The 
dynamical system representing the whole person is regularly exposed to more 
heterogeneous stressors than serum sodium changes, including potential 
stressors that are anticipated.  Allostasis has been used to describe “actively 
maintaining homeostasis” [27], but the practicality of this distinction from 
homeostasis is uncertain [127]. 
 
Some stressors represent state perturbations to which the person may respond 
without any obvious long-term negative ramifications. Some stressors, in part 
related to their chronicity, may have negative long-term ramifications. The 
perturbation may induce changes in several systems. For example, as time 
passes from the previous meal, a human’s stomach is growling and blood sugar 
is getting lower; the brain senses hunger and mobilizes to address the 
perturbation stressor. Part of the response to a stressor will be mediated directly 
by the internal environment without requiring any mediation by the brain, e.g., 
hunger causing the release of hormones to break down glycogen. Part of the 
response is directly mediated by the brain responsible for planning how to 
interact with the external environment, e.g., walking into the kitchen to get food. 
The perturbation may induce changes in physiological parameters, e.g., DNA 
transcription or epigenetic modifications to alter neurotransmitter receptor 
sensitivity. Responding to these stress perturbations may induce some cost to 
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the system. This cost may involve the movement of the system into another 
basin of attraction or an increase in the probability that the system will move into 
another basin following future perturbations.   
 
Though the stressor has some objective qualities, it can be difficult to quantify 
because physiological stress effects are highly dependent on the subjective 
perception. Quantifying an individual’s stressors has been attempted [128]. Some 
examples of stressors include events that have novelty, unpredictability, (any 
information-rich input beyond the brain processing ability), threat to one's ego, or 
sense of loss of control (NUTS) [129].  Short-term laboratory experimental 
stressors are related to these NUTS concepts including the Trier Social Stress 
Test, [130], the Montreal Imaging Stress Task [131], titrated Stroop color-word 
interference task [132],  physical (e.g., putting a hand in ice water) [133], or 
perceptual stressors (e.g., the disturbing pictures of the International Affective 
Picture Scale [134]).  Stress responses can also be conditioned [135] allowing for 
comparison between humans and other animals. It is more challenging to study 
long-term stressors experimentally but occasional misfortunes such as wars and 
other disasters have generated informative epidemiological data, e.g., the World 
Trade Center disaster. Stressors may involve awareness of a stressor, even if it 
is erroneous, e.g., misperception of an environmental change. Relevant 
examples include erroneous stress associations with ordinary loud sounds that 
have developed from explosion-related PTSD or a pheochromocytoma producing 
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a surge of catecholamines perceived as a stress state because of diaphoresis 
and a fast heart rate. 
 
In general, frequent perturbations into a stressed state away from the high utility 
attractor have a cost to the system. The cost of going to the refrigerator when 
feeling hungry is low. However, a related perturbation, the blood sugar increase 
and the need to secrete insulin due to overeating high-sugar items may 
eventually cause long-term negative effects. If repeated enough, it may diminish 
the human’s ability to stay in a positive functional attractor, and the lack of 
responsiveness to insulin at the cellular level (i.e., insulin resistance) may cause 
adult type 2 diabetes. This common stress-related change has resulted in a 
common diabetes measure, glycosylated hemoglobin HgbA1c, frequently used 
as a chronic stress biomarker. In humans, allostatic load is the cost to the system 
due to repeatedly returning to baseline, i.e., the costs of executing the 
physiological changes and the potential costs of making the changes in 
architecture of the basins of attraction (their size, depth, etc.) following a stressor 
as well as the eventual impacts of the architecture change. Allostasis has been 
used to describe the dynamical control over these variable perturbations for 
maintaining a functional state. Though there is some controversy over whether 
allostasis is truly different from homeostasis [127], the term allostatic load has 
been used as a conceptual measure of the physiological cost due to chronic 
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stressors [136] and be will be used in this paper. Attempts to define a metric of 
allostatic load for experimental use are discussed below. 
 
4. Measurement of stress 
The term stress describes a state of physiologic and behavioral responses to a 
stressor with the brain being the critical interpreter of what is stressful. Though 
inconsistently used, the stressed state in humans for the purposes of this 
discussion is linked to dynamical physiological change. The stressed state also 
involves the conscious and unconscious stressor interpretation by the brain 
including the conscious perception of the stressors and the perception of the 
physiologic response generated by the stressor [137-139]. Stressors result in 
changes in state variables and parameters and have been measured using 
various biomarkers.  
 
There are many objective ways to measure human stress responses other than 
commonly used self-rated scales. As previously noted, physiologic responses to 
stress include activation of the HPA axis, activation of the locus coeruleus-
norepinephrine-sympathetic nervous system pathway, the parasympathetic 
system, immune system, and genes [137, 139-143].  Importantly, the timing of 
these changes is variable. When measured as state variables, they may or may 
not shed light on the dynamical nature of the physiologic system, resilience, or 
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allostatic load. Dynamical aspects of stress and resilience may be estimated with 
repeated measurements over longer periods during daily routines or following a 
known experimental stressor.  
 
4.1. Peripheral biomarkers 
Each biological assessment has a sampling time window. For example, a 
peripheral blood draw to assess cortisol reflects cumulative changes over 
minutes, cortisol overnight urine collection measure reflects cumulative changes 
over hours, and a hair sample may reflect cumulative changes over months.  
 
HPA axis activity biomarkers include glucocorticoids: free cortisol (or 
corticosterone in experimental animals), ACTH, and corticotropin releasing 
hormone [144, 145]. In addition to acute stressor-induced changes in these 
biomarkers, there are alterations in diurnal fluctuations with chronic stress, e.g., 
in cortisol awakening response [85, 146]. Dehydroepiandrosterone (DHEA) and 
its sulfate (DHEAS) act to counter-regulate cortisol [147]. DHEA is used as a 
stress marker by itself [148] or as a ratio to cortisol and has been affected by 
depression [149]. Mineralocorticoids may also be stress biomarkers [150]. 
 
Several autonomic activity measures  are associated with acute or chronic stress 
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including blood pressure, electrodermal response, skin temperature, respiratory 
rate, heart rate and heart rate variability (HRV) [151]. A variety of HRV measures 
in the time and frequency domains have been evaluated [152, 153]. While HRV 
may look at dynamical changes over long periods, e.g., 24 hours or more, longer-
term HRV requires more sophisticated data processing to correct for exercise 
and unrelated to stress activities modifying the heart rate.  
 
Many measures correlated with stress have been treated as relatively static 
measures. There are alterations in immunologic function including cytokines; 
gene and epigenetic modifications involving telomere changes; and metabolic 
activity fluctuations resulting in generation of reactive oxygen and nitrogen 
species damaging to cellular structures [137, 141, 143, 154-156] .  
 
There are other biomarkers not directly related to the currently discussed 
physiological stress pathways. To assess stress responses researchers have 
used measures of muscle activity e.g., using electromyographic activity for 
biofeedback in treatment of muscle contraction and other types of headaches. 
Biofeedback has been used on many physiological measures with only few 
(peripheral temperature and electrodermal activity) being closely related to ANS 
activation [157].  Additionally, as many have casually observed, stress alters 
voice characteristics [158] and posture in a chair [159]. Other biomarkers are 
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listed below under allostatic load. 
 
4.2. Brain changes 
4.2.1. Cognition 
Cognitive function including memory is significantly altered by stress in humans 
and non-human animals [117, 160, 161].  Cognitive decline associated with 
stress (and the closely related construct depression) may affect speed, attention, 
and executive function [117, 162]. Prefrontal cortical dysfunction is particularly 
impacted by stress [163].  This pathological relationship becomes more evident 
with age [28], and highly stressed elders such as dementia caregivers may be 
particularly at risk [155]. 
 
4.2.2. Structural brain changes  
Stress-related states such as PTSD and fear conditioning are linked to 
decreased hippocampal size, decline in prefrontal cortex, increased size of 
portions of the amygdala, and decreased inhibition of the amygdala and related 
brain regions by the frontal lobes [161, 163-165]. The brain changes are at least 
partially mediated by cortisol with increased cortisol related to smaller 
hippocampi [166]. The time course of structural change is much longer than the 
half-life of cortisol; cortisol elevation needs to be sustained to cause longer-
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lasting brain changes. Smaller hippocampi are common among people with 
PTSD or trauma exposure [167, 168] and they also are linked to increased risk 
for PTSD development [169] so the causative relationship is uncertain. Further, 
PTSD sufferers are at higher risk of dementia [170] and those with smaller 
hippocampi have increased the risk of dementia [171]. Therefore, defining the 
causative aspects of these relationships is critical and can affect other important 
health concerns. From the perspective of beneficial effects, research shows 
increased hippocampal volume and improved verbal declarative memory in 
PTSD patients after  using a selective serotonin reuptake inhibitor (SSRI) 
antidepressant for  9-12 months [172]. This is likely related to SSRI-related 
neurogenesis increase [173].  
 
4.2.3. Physiological brain changes: EEG, event-related potential, fMRI 
EEG stress-related changes, particularly frontal asymmetries [174, 175], and 
alterations in event-related potentials [176] have been noted, but these changes 
have not been consistent, in part due to lack of distinction between state and trait 
markers and limitations in signal processing [177]. Chronic psychological stress 
impairs sleep and the resultant sleep deprivation may impact EEG. PET and 
fMRI detect brain activation changes due to experimental stressors [63, 178, 
179].  
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4.2.4. Genetic changes in brain 
There are different functional gene classes that underlie the diverse effects of 
glucocorticoids on brain function, e.g., energy metabolism, signal transduction, 
neuronal structure, and neurotransmitter catabolism [140]. Stress effects on 
telomeres have been mentioned but assessments of human telomeres are 
generally performed on peripheral blood limiting their direct brain association. 
 
4.3. Allostatic load 
The underlying biological definition of allostatic load is very broad since the 
physiological system represents a highly multidimensional state space with many 
parameters. Potential examples of underlying load include the cost of gene 
transcription, metabolic activity, and alteration in cell receptor sensitivity. 
Frequent DNA processing may produce changes in telomere length. 
 
Allostatic load was originally developed as a composite marker of chronic stress-
related disequilibrium generated from a number of physiological measures. The 
originally described allostatic load score was a composite of 10 measures 
(systolic and diastolic blood pressure; waist-hip ratio; ratio of total cholesterol to 
high density lipoproteins; high density lipoprotein cholesterol; glycosylated 
hemoglobin; overnight 12-hour urinary cortisol, epinephrine and norepinephrine; 
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and DHEA-S [180]. The score obtained by summing the ten measures (0 if 
normal, 1 if 75th percentile or worse) was associated with mortality. Related 
composite allostatic load measures have been correlated to childhood poverty 
[181] and measures of work exhaustion [182]. The latter study added several 
measures (tissue necrosis factor-alpha, C-reactive protein, fibrinogen, and D-
dimer) and other measures have also been added, e.g., pro-coagulant activity. 
Despite the widespread interest in allostatic load, the optimum measure has not 
been defined; the measures currently used are based on non-experimental 
approaches (e.g., simple availability and a priori rationales). As a result there is 
much variety in the definition of a composite measure [183], but there needs to 
be improvement in its definition to advance the field of biomarkers for chronic 
psychological stress. This could potentially result from better analytic techniques. 
 
Allostatic load measures have highly variable time frames. Some may change 
relatively quickly, e.g., fibrinogen, some are integrated over some time period 
(e.g., 12-hour urinary cortisol), and some change much more slowly or are 
integrated over longer time frames (e.g., waist-hip ratio or HgbA1c). Most 
physiological parameters are not only stress indicators but also change with 
other biorhythms, e.g., circadian or prandial. 
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Another rationale for allostatic load as a composite measure of stress effects is 
that different people likely have different subsystems affected by stress. Some 
people experiencing high stress develop headaches, while others develop 
gastrointestinal or other disorders. The particular organ systems affected by 
stress is an interaction between these systems and the brain. The individual 
reactions to stress are dependent on an individual’s genes, learning and 
environment. Thus, it is likely that different people have different patterns of 
alteration in stress-related biomarkers or allostatic load component measures 
that may potentially be discerned by better analytic techniques, e.g., structural 
equation modeling or machine learning. It may ultimately be important to 
understand the individual relationships, but at this state of the research it may be 
helpful to have a combined measure. 
 
4.4. Stress and disease  
Acute stress may have some metabolic, immunologic and cognitive benefits. For 
example, alterations in system properties may produce a higher transient utility, 
decrease the likelihood that a stressor will move the state of the system away 
from an optimal attractor (robustness), or increase the size of an attractor basin 
(see hormesis below). A helpful example is the immune system which learns to 
react to foreign substances when exposed to non-virulent ones that do not result 
in death. If the immune system is not exposed to sufficient foreign substances, 
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the result could be over-reactivity to foreign substances or allergies [184]. 
However, as stated in the introduction, more often impairments in health and a 
broad range of diseases are produced by chronic psychological stress.  
 
Chronic stress may cause cognitive decline, adverse effects in the hippocampus, 
and contribute to neurodegenerative diseases either directly or through stress 
mediators including allostatic load [24, 25, 27, 117, 185]. The negative effect of 
psychological stress on cognitive function may be greater with aging [28-30]. 
Stressors including anesthesia, drugs, depression may be more likely to result in 
a state of impaired cognitive function with increased age. Cognitive reserve, a 
measure of how well the brain works [52], may be one aspect of resilience to the 
effects of stress on cognition.  
 
5. Dynamics of stress system - time course of stress-induced physiological 
changes: state/trait and variables/parameters (Figure 2.4) 
Stress can cause a perturbation of state but the associated changes to 
physiological measures occur at varying time scales. The time courses of marker 
changes in psychology are sometimes grouped into fairly mobile, shorter-term 
changes reflecting the person’s current state and longer-term, more stable 
changes reflecting traits. Standard measures of psychological stress aspects, 
such as anxiety, are often measured by a widely used inventory, e.g. the State-
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Trait Anxiety Inventory [186]. However, even relatively stable traits, such as the 
personality trait neuroticism, often considered stable over a lifespan, can be 
malleable thus limiting the clear distinction between state and trait. Systems 
science uses terms analogous to state and trait: variables reflecting current state 
measures and parameters reflecting more stable attributes of the system. The 
change in parameters may decrease the likelihood of the system staying in the 
optimal attractor basin in the face of typical environmental fluctuations, but the 
distinction from variables is simply the time scale and thus is somewhat artificial. 
This section is focused on the varying time courses of physiological makers 
which are only moderately correlated with commonly used self-rated markers. All 
biomarker measurements, including common physiological measurements (e.g., 
cortisol) and many anatomic and experimental physiological measurements (e.g., 
hippocampal size or neuronal receptor sensitivity) change over time, but the time 
courses differ.  
 
The sympathetic branch of the ANS is the quickest to respond. Stress response 
can be measured by heart rate, blood pressure, electrodermal activity, or 
catecholamine release [187]. Epinephrine and norepinephrine release occur in 
seconds. The two-minute half-life of epinephrine highlights the generally short 
time course of this response. This ANS response is presumably geared to short-
acting flight-or-fight changes such as metabolic needs, blood flow, and non-
specific alerting of the brain [188], with norepinephrine projecting throughout the 
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brain contributing to both phasic and tonic alertness [189, 190]. HPA activity has 
a slower time course and is activated by threats and negative consequences 
even when only anticipated. Cortisol has effects throughout the body and is 
impacted by many factors other than stress. Cortisol also directly affects the 
brain via cortisol receptors present in the pituitary, cerebellum, hypothalamus 
paraventricular nucleus and in neocortex. The cortisol peak onset occurs 15-30 
minutes after a stressor [178, 191].  
 
Stressor effects on the immune system have a long-time course, and effects on 
learning and DNA have even a longer-time frame and are important for sustained 
stress effects. Some personality traits have been linked to specific genotypes, 
e.g., single nucleotide polymorphisms. For example, a specific genotype 
(5HTTLPR) relevant for stress affects serotonin transport and has been related to 
stress reactivity [192] and the personality trait of neuroticism. Particularly relevant 
for our discussion involving time courses in human stress are the brain network 
changes altering perception of the stressfulness of an environmental stimulus; 
this may be related to sudden awareness (consciousness) of the stressor or of 
the induced physiological state change. A system that reacts differently if 
consciousness is achieved and responds based on conscious perceptions and 
concepts, such as the perception of causality, is inherently biased. 
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There are different approaches to measure stress and resilience dynamically. 
One can measure the magnitude of the change at some time point following a 
stressor, e.g., the cortisol increase from baseline to 15 minutes after an 
experimental stressor. One can incorporate a more sophisticated temporal 
measure estimating the area under the curve or half-life of a biomarker stress 
response if enough assessments are available. Another measure is the time it 
takes to return to baseline following an experimental stressor, e.g., fMRI changes 
2 hours after a stressor [63]. In the event one does not use an experimental 
stressor, one can observe response following a significant environmental 
stressor, as in epidemiological studies related to war injuries or catastrophes. If 
enough measurements over sufficient number of days are available it is possible 
to calculate the variability of the physiological system. This variability of the 
system relates to stress responses but other variables (e.g. age) enter as well. 
For example, aging is associated with increased variability of measures of 
performance, and this variability can serve as a marker for insipient dementia 
among elders [193].  
 
In general, the slowly changing traits or parameters are potentially harder if not 
impossible to measure empirically. Given the variable time frame of the 
biomarkers, assessment by many repeated measurements over a prolonged 
period may provide a better representation of the dynamical stress system 
response to psychological stress than single time-point assessments. This is 
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especially true because each biomarker already captures the physiological 
system over some cumulative time window. The many physiological 
measurements needed over a prolonged time can be obtained over days or 
weeks using continuous recording in a lab or repeated assessments using 
ecological momentary assessment [194, 195]. Looking at reactivity to an 
experimental laboratory stressor may also provide good markers of the dynamic 
nature of the physiological system related to stress. Epidemiological studies can 
use data acquired following population exposure to a common stressor. Figure 
2.4 offers a schematic representation of the conditions related to shorter- and 
longer-term stressors and physiological responses. There are many systems 
science methodologies that could be used to analyze the multidimensional 
nature of stress physiology including system dynamics modeling, agent-based 
modeling, network analysis, discrete event analysis, Markov modeling, and 
control systems engineering [119]. 
 
6. Resilience 
As discussed in the introduction, the term resilience has been used in different 
ways. Resilience affects how effectively and quickly the system returns to a high 
utility attractor basin [44]. Despite the neuroscientific interest in resilience [45, 
57], its definitions remain variable. Resilience or robustness is the capacity of the 
system to return to a high utility attractor following perturbation, the system’s 
ability to avoid shifting to another attractor basin presented in this paper as a 
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dysfunctional or diseased condition, or moving more quickly to its optimal 
location within its original attractor basin (Figure 2.1). Specific examples of 
resilience from a systems perspective include: 1) the distance of a location in one 
attractor basin to the boundary of an adjacent basin of inferior utility, i.e., greater 
resilience means the attractor is further away from boundaries with low utility 
neighboring regions; and 2)  the strength of the vector field in the basin, where 
resilience might mean more rapid return to the attractor, so a repeat of a state 
perturbation before full return will make leaving the basin less likely. From a 
biological perspective, resilience may refer simply to the ability of a person to 
cope with a significant external stressor or insult. Related terms include: stability 
or resistance, indicating the difficulty moving a system away from its baseline 
"optimal' region; precariousness suggesting system proximity to some threshold 
of moving into another attractor basin, and latitude related to the maximum 
amount of change the system undergoes before losing its ability to remain within 
its high utility attractor basin. The resilience of a dynamical system to maintain 
itself within a functional high utility attractor basin is very important to the long-
term health of the system. Resilience is not simply the opposite of allostatic load. 
Allostatic load is a measure of physiological system parameters that may impact 
resilience but it also has other effects on long-term health or disease risk.  
 
It is known that many human stressors are best remediated by significant 
behavior change affecting stressor exposure (e.g., ingesting less glucose if pre-
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diabetic or decreasing work hours in a stressful job if hypertensive); some 
stressors in humans are related to the perception of the stressor more than the 
stressor itself. For example, someone with PTSD is in a pathological lower utility 
attractor that could relate to the brain misperceiving the environment in a way 
harmful to the person's health (e.g., a truck backfire causing a veteran to engage 
in recollections and emotions associated with war).  
 
Resilience to psychological stress is evident when some people avoid significant 
psychopathology, such as PTSD and depression when exposed to a stressor 
[45]. In the World Trade Center disaster resilience, measured by a likelihood of 
developing PTSD, was related to age (older did better), gender (males did 
better), social support (more did better), self-esteem (higher did better) and 
lifetime history of depression (worse with a positive history), but was not related 
to education [47]. 
 
Some amount of stress in the environment may be useful for maximizing the 
system's ability to respond to future stressors. Humans living with no stressors 
may lose the ability to respond to future stressors. From the brain perspective, 
some amount of stress is useful for maximizing learning and maintaining 
cognitive function. Systems that learn to cope with some amount of stress may 
be less affected by future stressors. Hormesis refers to a biphasic response to a 
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stressor, “a process in which exposure to a low dose of an environmental factor 
that is damaging at higher doses induces an adaptive beneficial effect on the cell 
or organism" [65].  This adaptation could be to environmental stressors such as 
cold and exercise [66]. A stressor can cause the system to be non-optimal for a 
short time but still result in returning to baseline. While there may be some 
allostatic load cost, the stressor may induce changes in system physiological 
parameters that strengthen the future ability to return to its greater utility 
locations, i.e., increase resilience. This low level of stress exposure occurs in 
some clinical treatments, e.g., allergy therapy and exposure therapy in PTSD. In 
some sense such exposures to a low-level stressor is a way to exercise the 
resilience aspects of the system. In general, repeated external stimuli elicit less 
of a physiological response because of habituation that can be measured by 
fMRI, event-related potentials or electrodermal response [196, 197]. However, in 
some cases repeated external stressors result in the excessive response, as in 
PTSD (e.g., hyperarousal to loud noises) and become self-reinforced rather than 
extinguished.  
 
This decreased efficiency and ability of the human dynamical physiological 
system to stay in or get back to a functionally positive attractor basin is the 
negative effect of chronic stress or allostatic load.  Changing the parameters of 
the human system to bring the system back to the optimal state or high utility 
attractor often entails a cost to the basic human constituents but the changes can 
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be used to simply indicate previous stress exposure. This could be DNA 
modification, receptor sensitivity changes, or changes to blood vessels from high 
blood pressure. Another example of changes to the underlying system is aging, 
which can make a person more likely to exist in a non-optimal state or attractor 
basin. It could be that the attractor basin becomes smaller or less steep. The 
change of the state space attractor basin that decreases the system’s ability to 
stay in its higher utility states without moving to lower utility states in its current 
attractor basin or to a lower average utility attractor basin represents the chronic 
stress effect or allostatic load. These changes over time can be defined 
mathematically. The suboptimal attractor basins do not become necessarily 
larger; rather, the high utility attractors become smaller with shallower sides. 
Thus, the time required for return to the baseline state tends to increase.  
 
From a probabilistic perspective, the resilience of the system could be 
considered the probability that an environmental perturbation results in returning 
to the high utility attractor basin, as opposed to ending up in an attractor basin 
with lower utility. The capacity of a system to stay in a high utility attractor basin 
could be defined stochastically: the likelihood that following a particular 
perturbation the person returns to the high utility attractor basin. The capacity to 
stay in this high utility attractor basin is especially relevant when, following a 
stressor, the state may be closer to the basin boundary and be more likely to shift 
to a non-optimal attractor basin should another stressor manifest. Even without 
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changing the specific attractor basin but simply the shape of the basin, resilience 
could be defined based on the probabilistically weighted average utility in a single 
attractor basin following expected stressors. 
 
PTSD is a useful example of state space and attractors since some of the 
physiologic responses may initially have been an adaptive response during 
specific time and environment but when they persist in other environments, the 
result is moving to a lower utility attractor where the abnormal response is self-
reinforcing. A high stress physiological state may be high utility during a war but if 
that state persists after returning home it can be lower utility.  The transition to 
PTSD is not reversed immediately as soon as causes are reversed or disappear. 
Reversal might require going all the way back to an earlier state in a system 
which induces the possibility for a cusp catastrophe (Figure 2.2). 
 
7. Environment and its perception 
In addition to knowing the physiological state of the person, one should also 
know the state of their environment because certain physiological measures may 
be a reaction to the environment. It must be reiterated that although some 
environmental stressors have a direct effect on stress responses, e.g., extreme 
cold, stress responses are significantly related to the person’s perception of the 
stressor. The perception of the environment (Figure 2.3) is affected by a person's 
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prior experiences through attention and memory.  Many environmental stressors 
are stressful because of the way they are perceived and processed.  A person 
focused on an important phone call may not realize it’s hailing outside because of 
their attention on call. As a result, one may not be worrying about whether the car 
was left outside the garage. Attention refers to systems in the brain that allow 
some information to be processed more than other information [198]. Memory is 
a broad term with many subsystems loosely divided into declarative and non-
declarative memory [199].  Emotional memory has critical brain hubs not relevant 
for other types of memory. The amygdala rather than the hippocampus is critical 
for registering the emotional valence of an event [200]. Beta-blockers that block 
aspects of the ANS can have an impact on emotional memory without any impact 
on episodic memory [200, 201]. The memory-induced changes in neural 
connectivity that result from gene expression and protein synthesis require hours 
to days. A person with a memory of a previous environmental stressor will 
perceive the perturbation differently from the person with no prior associations to 
it. For example, a physically abused wife might associate the noise of her 
husband returning home with the physical abuse that often follows. The sound of 
an opening door will have different neural associations to her than her non-
abused neighbor.  
 
High reactivity to negative events produces physiological changes [32]. In fact, 
negative reactions to events are more predictive of emotional well-being than the 
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event itself [33]. Reactivity to stress can be examined though neuroticism, one of 
the five factors in the widely used five-factor personality inventory [202]. 
Neuroticism has genetic, neurobiological, and environmental contributions [30, 
34, 35]. High neuroticism contributes to many health disorders [36] and relates to 
increased age-related cognitive change and clinical Alzheimer’s disease in 
longitudinal studies [37-39].  The cognitive deficits related to distress proneness 
are not specific and most consistently included frontal-executive function and 
perceptual speed [37, 39], not dissimilar to cognitive changes associated with 
affective disorders such as PTSD and depression [40, 41]. Neuroticism with its 
negative effects on cognition is a modifiable risk factor [42] with a potentially 
large impact on population health [43].  
 
The internal physical components of the human are part of the brain 
environment, considered the internal environment in contrast to the external 
environment located outside the physical body. The brain has partial awareness 
of the internal (interoception) and external (exteroception) environment. 
Interoception and exteroception may produce brain and other physiological 
changes without awareness, but humans can become aware of their internal 
states such as anxiety or stress. Interoception may be taught as awareness and 
control over internal organs (e.g., learning to modulate one's blood pressure 
through biofeedback or mind-body practices).  
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As previously mentioned, the effect of an environmental stressor on health may 
be modified by how the brain perceives the environment. This perception can be 
altered by higher level concepts beyond attention and memory as highlighted by 
the concept of hope. From a health perspective, optimists fare better than 
pessimists [203] and those with higher religious involvement and spirituality do 
better than those with lower involvement [204]. The beneficial placebo response, 
i.e., the improvements in physiological measures or perceptions of health 
following administration of a treatment without any direct biological affect, can be 
elicited by merely telling someone that a treatment may work (even if there is no 
directly active components in the treatment) [115, 205]. It is likely that some 
mechanisms of placebo or expectancy effects overlap with some of the 
mechanisms underlying perception of stress [206]. The major stress hormone 
cortisol can be altered by experimental manipulation of expectancy in placebo 
effect studies [207, 208]. 
 
8. Stress and resiliency biomarker changes with treatment 
There are physiological and genetic markers associated with improved resilience 
to stress-induced physiological changes [41, 209, 210], and there are also 
psychological tools to increase resilience, or the ability to tolerate stress 
perturbations without decreasing utility. Exposure therapy has been used to 
reduce the person’s reactivity to stressors, e.g., an allergen or an environmental 
stimulus precipitating PTSD symptoms. Mind-body techniques and biofeedback 
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provide cognitive strategies to decrease emotionally-activated responses, avoid 
unnecessary negative internal associations (i.e. sense of stress) to current 
events, and to maximize capacity to return to a positive state attractor following a 
stressor.  
 
A key facet of many mind-body therapies is mindfulness, attending to the present 
moment in a non-judgmental way. With several ways to measure mindfulness, 
the judging and negative appraisal of thoughts, emotions, and behavior factor 
may be particularly important for stress management. The mindfulness-non-
judgmental score, i.e.,  being aware of the environment without attaching an 
emotional tag [88], is diminished by the chronic stress in dementia caregivers 
and in veterans with post-traumatic stress disorder [30, 211].  
 
Mind-body studies have suggested biomarker changes related to mindfulness or 
mindfulness training partially overlap with the allostatic load biomarkers but in the 
opposite direction. These include telomerase[212], immune function [213, 214], 
cognitive function [214, 215], catecholamines [216], HRV [217], cortisol [214, 
218-220], EEG [112], structural MRI [221, 222] and fMRI [223].  Meditation alters 
physiological responses to an experimental stressor [93]. However, the preferred 
or composite biomarkers relating to benefits of mind-body medicine have not 
been identified.  
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9. Utility 
Utility is essentially the same as success of the organism (e.g., life, procreation 
or, in the case of humans, earning money). Long-term health is an important 
focus of the utility definition concerning stress-related impact on human health. 
While utility is the benefit to the person (or genes), the benefit also depends on 
the environment, i.e., the specific calculation of utility varies with the environment 
and the time course over which it is calculated. During war, utility is more 
immediate, perhaps simply surviving to the next day with a very high discount for 
future situations. Therefore, utility of a response to a stressor depends on the 
environment and on a person's degree of discounting future events. Thus, the 
calculation of utility in different environments will be dependent on the rewards 
and penalties in the current environment and on the time duration and differential 
weighting used for calculating the utility.  
 
10.  Conclusions 
This paper has described human stress physiology and psychology from the 
systems science perspective. Specifically we focused on environmental 
perturbation stressors that produce significant long-term changes in the human 
dynamical system. Acute stressors usually do not produce long-term negative 
effects although a significantly powerful acute stressor may push the brain 
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dynamical system into a new, functional attractor basin with lower utility. In 
general, chronic psychological stress produces changes in the system, such as a 
slower response to a future stressor or a higher potential for moving to a new 
lower utility attractor basin. If a human is exposed to a “tolerable” dose of a 
stressor that results in return to the original high utility attractor basin, the 
outcome may be improved resilience.  From a systems science perspective, 
behavioral and physiological measurements attempting to capture the degree of 
stress of a system should incorporate the dynamics of the physiological stress 
response system as well as some measures of the environmental stressors and 
their perception. Understanding stress will require all of the interacting 
components from Figure 2.3 to be measured and described, at least partially. In 
general, the systems dynamics of stress physiology has much less temporal 
empirical data to inform the model than, for example, meteorological data 
because of the difficulty acquiring the human data. Nevertheless, analyzing 
dynamical data will be important to better understand stress physiology since the 
timing and strength of feedback loops likely contributes to disorders of stress and 
resilience to stress. In addition to measuring stress responses over time, it may 
be useful to repeat administration of experimental stressors to understand self-
reinforcing loops. These  systems science concepts and better measurement 
techniques will lead to better understanding of the stress system that  ultimately 
can be used to improve the resilience of the human system and thereby improve 
long-term health. 
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Figure 2.1. Schematic of attractor basins for high and low resilience.  
Hypothetical example of space of possible human physiological states with two 
attractor basins, one being a healthy higher utility condition and one a lower utility 
condition state of PTSD (in this figure, higher utility is downward). The attractor 
basins can tolerate movement of the hypothetical person (solid circle) in the 
horizontal direction from an external stressor without leaving its basin of 
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attraction. However, with sufficient movement from a stressor, one may go from a 
higher utility healthy condition basin to a lower utility PTSD basin. The healthy 
condition in b has lower resilience than in a, with less stress required to shift it to 
the lower utility basin.
Figure 2.2. Schematic of cusp catastrophe for post-traumatic stress disorder. An 
example of a cusp catastrophe where the state space of human physiology has a 
complex 3-dimensional shape, with no pictorial representation of attractors, and 
there may be an abrupt state change. In this example, as stress increases at 
higher levels of depression there may be a sudden drop in location to a new 
state, PTSD (marked by a dotted line). Here, utility is up rather than down as in    
Figure 2.1                          
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Figure 2.3. Stress system with input, brain, effectors, and moderators 
(2.3 Top) The brain’s perception of the emotional valence of an external event as 
a stressor is dependent on the current environment and modulated by previous 
experiences (memory), current physiological state, traits (e.g., neuroticism), and 
genotype.  The brain generates outputs to the autonomic nervous systems 
(ANS), the hypothalamo-pituitary-adrenal (HPA) axis, the immune system, gene 
expression and epigenetics (overall increasing time duration of stress activation 
components from left to right. These responses directly affect the body but also 
feedback to the brain. Learning includes assessment of risks and rewards and it 
can be clinical designed to reduce reactivity, e.g., allergy therapy or mindfulness 
meditation. (2.3. Below). Example of self-reinforcing stress response system that 
is pathological if in a non-threatening environment. Normally, while stress 
activation from a loud non-threatening noise may initially activate a stress 
response, response to repeated loud noise will be attenuated through negative 
feedback (e.g., habituation). In PTSD emotional memories and the stress 
activation itself may contribute to an auto-reinforcing positive feedback loop. As 
mentioned in the text and Figure 2.2, this PTSD attractor basin may be entered 
secondary to a single severe negative event via a catastrophic dynamical 
systems event. This pathological transition is more likely in those with 
predispositions, e.g., neurotransmitter alterations such as depression. 
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Figure 2.4. Potential state examples based on 3-dimensional stress model 
A rough schematic of three dimensions related to stress. Physiological activation 
can be low or high and sustained for a short or long period of time. The response 
can be to a stressor that is relatively low from an objective or population 
perspective or relatively high. Normal function usually goes from relaxation state 
(a) to short duration high physiological activation when exposed to a stressor (f). 
If the stressor response is too sustained or occurs too frequently, there is some 
cost to the system. 
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Chapter 3.  
Meditation in stressed older adults: effects on stress, affect, cognition, and 
physiology. 
 
 (edited version submitted to Psychology and Aging, January 2016) 
 
Abstract 
Objective: Determine if mindfulness meditation (MM) in older adults will improve 
measures of psychology, cognition and physiology impacted by stress. 
Methods: 134 at least mildly stressed 50-85 year olds were randomized to a six-
week one-on-one MM intervention along with home practice or to a wait-list 
control (ClinicalTrials.gov  NCT01386060). Outcome measures assessed at 
baseline and two months later at Visit 2 included Positive and Negative Affect 
Schedule (PANAS), Center for Epidemiologic Studies Depression (CESD), 
Perceived Stress Scale (PSS), Neuroticism-Extraversion-Openness (NEO) 
personality traits, SF-36 health-related quality of life, a broad cognitive function 
battery with emphasis on attention and executive function, salivary cortisol, 
respiratory rate, and heart rate variability. 
Results: 128 participants completed the MM study though Visit 2 assessments. 
Self-rated measures related to negative affect and stress were all very 
significantly improved as a result of the MM intervention (PANAS-negative, 
CESD, PSS, and SF-36 health related quality of life (Vitality and Mental Health 
Component). There were significant changes in some personality traits especially 
Neuroticism. Positive affect were not significantly changed. There were no 
changes in cognition, salivary cortisol, and heart rate variability. 
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Conclusion. Mental health in the MM intervention group was significantly 
improved compared to the wait-list control, with some clinically important 
differences in SF-36 Vitality and Mental Health Component scores. These self-
rated improvements were not paralleled by improvements in cognitive function or 
physiological measures. Potential explanations for this discrepancy in stress-
related outcomes are discussed at length. 
 
Keywords (up to six) 
Meditation, stress, cognition, fatigue, mental health, older adults 
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BP – Blood Pressure 
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PTSD – Post traumatic stress disorder 
PSS – Perceived Stress Scale 
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PSQI – Pittsburgh Sleep Quality Inventory 
NEO – Neuroticism-Extraversion-Openness 
SF-36 – Short form 36-item health related quality of life 
FDR – False discovery rate 
MM – mindfulness meditation 
Resp - Respiration 
SDRR – Standard deviation of inter-beat interval 
WAIS- Weschler Adult Intelligence Scale  
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Currently, age-related cognitive decline stands as a major public health issue, 
with high societal costs and few preventative options. The prevalence of 
cognitive decline associated with functional impairment, referred to as dementia, 
is about 14% of Americans over 71 years old [1] with a resultant high cost to the 
US of $200 billion [2]. Cognitive impairment without dementia in those over 71 is 
even more prevalent, affecting about 22% of the population [3]. Older adults are 
more likely to develop cognitive symptoms from medical conditions. For example, 
in addition to slow progressive cognitive decline, older adults are much more 
likely to develop significant, transient cognitive impairments, even to the point of 
delirium. A weakening of overall brain function could be caused by depression, 
nutritional deficits, oral medications with central nervous system effects, 
anesthetics, or simple hospitalization [6-8]. This point highlights how older adults 
are more susceptible than younger adults to any process that negatively affects 
brain function. Despite the personal and societal costs and known 
epidemiological risk factors, such as hypertension and low education, there are 
no evidence-based recommendations for prevention of age-related cognitive 
decline [4]. Mildly improving cognition and delaying the onset of dementia by 
even 6 months with a widely available behavioral intervention would decrease 
the number of dementia cases by over 100,000 over 10 years [5]. Developing 
evidence-based strategies to decrease the negative impact of depression and 
stress that contribute to age-related cognitive decline was one goal of this study. 
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Psychological stress is one important factor in the general population and 
specifically with older adults that can be addressed by behavioral interventions. 
Psychological stress is very common and contributes to many physical and 
mental health problems. About 25% of surveyed American adults reported high 
stress and 50% reported a major stressful event over the past year [9]. Stress is 
potentially caused by events with Novelty, Unexpectedness, Threat to ego, or 
Sense of not being in control (NUTS) [10]. Chronic psychological stress has 
multiple effects on physiological systems [24, 224] and the underlying 
pathophysiology of stress-related symptoms, contributing to a broad range of 
diseases, such as cardiovascular health [11-14], epilepsy [15], Parkinson's 
disease [16-18], multiple sclerosis [19, 20], eating disorders, and addictions [21]. 
Stress may also worsen behavioral symptoms, such as anger and anxiety, which 
symptomatically worsen disorders such as traumatic brain injury, post-traumatic 
stress disorder (PTSD), and dementia. Importantly, chronic psychological stress 
and excessive reactivity to stressors contributes to age-related cognitive decline, 
hippocampal injury, and neurodegenerative diseases either directly or through 
stress mediators [14, 22-27] with the effect being even greater with aging [28-31]. 
Higher reactivity to negative events produces physiological changes [32]. In fact, 
negative reactions to events are more predictive of emotional well-being than the 
event itself [33]. Elevated stress reactivity associated with negative emotions, 
neuroticism, has genetic, neurobiological, and environmental contributions [30, 
34, 35]. High neuroticism contributes to many health disorders [36] and is linked 
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to increased age-related cognitive change and clinical Alzheimer’s disease in 
longitudinal studies (although the neuropathology of this cognitive change or 
clinical dementia syndrome is not related to amyloid deposition) [37-39].  
Proneness to distress elicits deficits that are not specific and consistently include 
frontal-executive function and perceptual speed [37, 39], similar to cognitive 
changes associated with affective disorders such as PTSD and depression [40, 
41]. Reducing stress reactivity and thus its negative effects on cognition may be 
a modifiable risk factor with a potentially large impact on population health [43].  
 
Mindfulness meditation (MM) is a behavioral intervention that shows promise in 
being able to reduce stress and stress reactivity in many health conditions. MM is 
a popular meditation approach that has been formally studied and applied in a 
variety of clinical conditions including PTSD, depression, pain, and stress [75-
83]. However, the evidence for efficacy has not been definitive across the board 
in part related to lack of objective not self-rated markers of improvement [84-86, 
225] although there is moderate evidence for the reduction of anxiety, depression 
and pain symptoms [86, 87, 225]. Mindfulness meditation has not been well 
evaluated in older adults as a behavioral intervention to reduce stress and stress 
reactivity and thus, potentially improve cognitive function. 
 
Goals of study 
The goal of this study was to further elucidate and better define the benefits of 
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MM training in older adults using a broad battery of outcomes related to stress, 
physiology, and cognition. This goal was accomplished by examining which 
outcomes have greater effect sizes from MM training. In a randomized controlled 
trial, mildly stressed older adults were allocated to a six-week one-on-one MM 
intervention or a wait list control. We hypothesized that psychological, cognitive 
and physiological  measures related to stress would improve with the MM 
intervention. 
 
METHODS 
Participants  
Participants consisted of generally healthy adults 50-85 years of age who 
reported at least mild levels of stress. The upper age cutoff helped to limit 
instances of multiple brain pathologies contributing to age-related cognitive 
alterations [55, 226, 227]. Participants were recruited from the Portland, Oregon 
metropolitan area.   
 
Following inquiries, participants were informed about the study and eligibility 
criteria. If interested, they underwent a 30-minute telephone eligibility screening 
for which there was an IRB-approved Waiver of Authorization granted where 
health history and demographic data were collected and several questionnaires 
were administered. This study was approved by the Oregon Health & Sciences 
University Institutional Review Board (IRB) and was registered with 
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ClinicalTrials.gov (NCT01386060). Participants provided informed consent during 
Visit 1 at the research lab. Exclusion criteria were primarily to screen out an 
underlying illness that might limit the benefit of the intervention, confound 
outcomes, or increase the likelihood of dropout (Table 3.1). 
 
     Table 3.1: Inclusion and exclusion criteria 
Inclusion 
Criteria 
 Age 50-85 years old;  
 Baseline Perceived Stress Scale (PSS) [228] score ≥ 9;  
 Agree to follow the study protocol including randomization 
. 
Exclusion  
Criteria 
 Cognitive impairment (significant participant complaints) or a 
score of less < 30 on the Modified Telephone Interview for 
Cognitive Status (TICS-m) [229] 
 Significant patient-reported medical/neurologic disease (e.g., 
major organ failure; insulin-dependent diabetes, active cancer, 
or alcoholism); 
 Significant, untreated depression. Significant was defined 
based on Geriatric Depression Scale greater than 5 and 
interview; 
 Take medications known to affect CNS function or impact 
physiologic measures (e.g., steroids, neuroleptics or regular 
narcotic analgesics); stable doses of CNS-active drugs with 
less impact (e.g., beta-blockers, SSRI’s, and histamine 
blockers) were acceptable; enrolled participants were 
encouraged not to change their drug use during the study 
period and to inform the investigator if any change was made. 
 Cannot understand the instructions (e.g., cannot hear or see 
study materials or not fluent in English);  
 Prior experience with meditation classes or other mind-body 
classes (e.g., yoga or tai chi) within the last 24 months or more 
than 5 minutes daily practice in the last 30 days. 
 
64 
 
Randomization and follow up  
Following Visit 1, participants were randomized to a six-week one-on-one MM 
intervention or a wait list control.  All randomizations were performed by non-
blinded research personnel using a computerized covariate adaptive 
randomization procedure [230] aimed at balancing active and wait- list groups on 
age, gender, and baseline Perceived Stress Scale score using a pre-determined 
projected median split for the continuous measures. The research assistant who 
led the meditation training sessions performed the randomization, and the 
research assistants who conducted data-collection visits remained blinded. There 
were three assessment visits that were approximately three hours long and two 
months apart. Participants in the MM group received a 6-week one-on-one 
intervention adapted from MBCT [231] between Visits 1 and 2 but received no 
intervention between visit 2 and visit 3.  In contrast, participants in the wait list 
group received no intervention between visits 1 and 2, but received the 6-week 
one-on-one intervention between visits 2 and 3. This primary outcome paper 
analyzes only the Visit 1 and Visit 2 data. The outcome measures include: 1) 
self-rated measures of stress and affect and 2) biomarkers of stress including 
cognitive function, salivary cortisol, blood pressure, respiration rate, heart rate 
and heart rate variability (HRV).  
 
Intervention  
MM was the active intervention administered in this randomized controlled trial 
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(RCT). The intervention was administered in six, one-on-one training sessions 
occurring weekly and also involved recommended daily home-practice. As 
mentioned above, an unblinded research assistant delivered the training 
sessions.  
MM: The MM in this study is a standardized and structured one-on-one program 
[231] based on MBCT [232, 233]. The MM training objectives were to: 1) help 
participants understand their personal reactions to stress, 2) teach those skills to 
modify their stress reactions, and 3) promote their desire for self-care and 
feelings of competence and mastery. Participants attended 60-90 minute training 
sessions once a week for six weeks, and the six trainings all followed a similar 
format. The length of the sessions varied to some degree by weekly syllabus 
length and by participant characteristics. Most sessions began with a 30-minute 
guided meditation, followed by discussion about the participant’s meditation 
experience, conversation about establishing a regular home practice, 
presentation of new materials, and explanation of home practice. Formal 
meditation instruction included a 30-minute Body Scan, 30-minute Sitting 
Meditation, 30-minute Sitting with Difficulty Meditation, and 4-minute Breathing 
Space. Informal practice of mindful daily activities (e.g., washing dishes, eating) 
were taught to generalize mindfulness beyond the formal meditations. A brief 3-
Step Coping Space meditation was also taught as a quick coping strategy 
intended to be used during times of stress in daily living. The research assistant 
leading the MM intervention was educated in Buddhist meditation with previous 
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experience teaching secular 1-on-1 MM with adults enrolled in other RCTs [234, 
235]. 
 
Participants were instructed to practice at home 30-45 minutes a day as a goal 
but to practice at least some amount every day. The meditation home practice 
audio recordings had several possible shorter interval breaking points denoted by 
tones to allow flexibility for unpredictable time demands facing stressed adults. 
MM sessions will also offer strategies other than meditation for practicing 
mindfulness skills to cope with the many stressors that adults typically face.  
Wait-list: Participants randomized to the wait-list arm between Visit 1 and Visit 2 
received the MM intervention after the wait-list period (i.e., between Visit 2 and 
Visit 3). This was done in part to facilitate recruitment and decrease 
disappointment following randomization. 
Adherence (Compliance) and retention: Attendance at the weekly in-person 
sessions was tracked. Adherence to the MM home practice for the MM 
intervention was assessed by iMINDr, a software application on a study iPod 
Touch (Apple, Inc.) lent to the participants for the duration of the study [116]. All 
participants met with the non-blinded RA six times for 90 minutes during the 
active 2-month intervention block.  
 
Outcomes 
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The outcomes were self-rated questionnaires, cognitive assessments, and 
physiological measures. 
 
Self-rated measures (Stress, affect, personality and quality of life 
outcomes).  At all outcome visits, participants were assessed with self-rated 
measures that might be affected by the MM intervention or mediate the MM 
intervention effect on the objective measures. Forms were sent to participants 
prior to the in-lab assessment visits and were filled out at home, taking less than 
one hour to complete.  
 Stress: Perceived Stress Scale [228].  
 Personality: While neuroticism has been considered a stable trait, changes in 
neuroticism are a possible outcome from meditation studies [212]. Neuroticism 
was assessed with the shortened version of the NEO [202] that assessed the 
other personality traits as well.  
 Affect: Positive and negative affect schedule (PANAS) [236] and the Center 
for Epidemiologic Studies Depression Scale (CESD) [237]. While the 
conventional, standard, 20-question trait version of the PANAS was filled out at 
home, the 10-question state-version was filled out in the lab setting [236, 238, 
239] in preparation for its use in ecological momentary assessment. The state 
question PANAS asks participants “right now I feel …?” in contrast to the 
standard version that asks participants “Indicate to what extent you generally feel 
this way, that is, how you feel on the average.”  
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 Fatigue and quality of life:  The SF-36 health-related quality of life was 
administered. The outcome measures included the 4-question Vitality (Energy 
and Fatigue subscale) [240] that was previously found to be sensitive to yoga in 
two studies [241, 242]. Besides the Energy and Fatigue subscale, the Physical 
and Mental Health Composite summary scores were calculated using 
http://www.sf-36.org/nbscalc/index.shtml [243]. 
 Self-efficacy:  The General Perceived Self-Efficacy (GPSE) Scale [244] was 
included because participants have previously reported that their sense of control 
was significantly affected by meditation [107, 245, 246].  
 Mindfulness: Two factors from the Five Factor Mindfulness Questionnaire [88] 
were assessed: the Mindful Attention Awareness Scale and factor 5, mindful non-
judging. The latter was found in prior studies to be significantly different in 
chronically stressed populations, i.e., it was different between veterans with and 
without PTSD [211] and between dementia caregivers and non-caregivers [30].  
 Sleep: The Pittsburgh Sleep Quality Index (PSQI) [247] was administered 
because mind-body therapies improve sleep function [248] and may mediate 
stress effects on cognition [249]. 
 Expectancy/Credibility [250, 251] & Teacher Credibility [250, 252] were 
administered to determine if expectancy is associated with any improvements 
observed from the MM intervention.    
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Cognitive assessments were based on prior studies [30, 80, 107] and focused 
on attentionally demanding  frontal/executive function tasks but also included 
assessments of  episodic memory and reaction time. The cognitive outcome 
measures were: the Stroop Color and Word Test [108, 253]; a flanker attention 
test where participants decide whether a central arrow surrounded by flanker 
arrows is pointing left or right; the Consortium to Establish a Registry for 
Alzheimer’s Disease (CERAD) wordlist memory test (Morris et al 1989) that is a 
measure of episodic verbal memory where participants are read a series of 
words for later recall [254];  letter and category verbal fluency from the multiple 
form version of the Controlled Oral Word Associates test [255]; WAIS Letter–
Number Sequence that is a measure of working memory where participants are 
read a mixed string of letters and numbers and immediately state the string with 
the letters and digits each in their own alphabetic/numerical order [256] and; 
simple and choice reaction time [251]. The flanker attention test administered in 
the lab was sensitive to MM in a prior study [107] and to caregiving stress [30]. 
For the flanker task, to respond, participants tap on the left or right side of a 
touch screen on a hand-held device. The test has 30 congruent (flankers in same 
direction) and 30 incongruent (flankers in opposite direction) trials and lasts 2.5 
minutes. 
 
Physiological assessments were conducted at rest in the lab after 
participants had been seated for 30 mins and included the following: 1) systolic 
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and diastolic blood pressure (average of two obtained in succession using an 
automatic digital inflation cuff); 2) respiration rate using light elastic piezoelectric 
strap around chest near the diaphragm (Ambu-Sleepmate, Maryland) recorded in 
three consecutive 5-minute blocks when participant was listening to auditory 
recordings without any task and; 3)  electrocardiogram (ECG) for heart rate and 
conventional heart rate variability (HRV) frequency analysis measures [257, 258]. 
Respiration was recorded during three consecutive 5-minute time blocks while 
the participants were seated listening to audio without any task. Respiration rate 
was calculated in BrainVision. Breaths were labeled semi-automatically using a 
voltage trigger to label peak values. HRV measures from a 5-minute recording 
were low frequency  (LF, 0.04-0.15 Hz) to high frequency (HF, 0.15 – 0.40 Hz) 
ratio and standard deviation of the RR interval following methodology as used 
previously [153]. Electrodes were placed, amplified using BioSemi amplifiers, and 
ECG was processed using Kubios and BrainVision software. We also measured 
resting heart rate since previous findings suggested  that heart rate is more 
sensitive to mild mental stress than the typical HRV frequency analysis measures 
[153]. Saliva for cortisol was collected at home and analyzed as previously done 
[30, 259] with saliva samples obtained on two days at three time points: 
immediately on awakening, 30 minutes later and before bedtime. If participants 
followed directions and collected all samples, data was averaged across the two 
days. If for any reason a sample was missing, just a single day’s data were used 
rather than the average, knowing the single day measure might produce 
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significantly worse reliability [260]. Some have suggested more than two days of 
sampling per occasion but this study was constrained by budget to two days of 
sampling per visit. Thus, the cortisol outcome data for each visit consisted of a 
single salivary cortisol measure upon awakening, 30 minutes later, and just prior 
to bedtime.  
 
Analysis 
All data analyses were done in Stata 14 (StataCorp, College Station TX). Data 
were first inspected to ensure there were no outliers and extreme outliers (more 
than 4 standard deviations) were deleted. Data were assessed for normality 
using Shapiro-Wilk. Data transformations were used in the event of non-normality 
(e.g., square root or Box-Cox). Fisher’s exact test was used to compare the rate 
of study completion. 
 
The primary analysis for outcome measures was analysis of covariance of Visit 2 
outcome data by intervention group with the Visit 1 data as covariate. Age and 
years of education were entered as covariates for cognitive outcome measures 
given their known relationship and were kept in the model if their p value was 
less than 0.10. There are many potential outcome measures. One goal of this 
study was to evaluate the MM effect sizes on all the outcome measures and 
these are reported as partial eta squared. For multiple comparisons, the type I 
rate was controlled for using the false discovery rate (FDR) [261] with an overall 
FDR rate of 0.05. Both the unadjusted p values and FDR corrected p values 
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using R program p.adjust are provided in the outcomes table but p values 
mentioned in the results and discussion text are all corrected values. Pairwise 
Pearson’s correlation coefficients and unadjusted p values were calculated to 
better understand the relationships of the many self-rated measures. 
 
Meditation home practice time was an important and objective measure of 
adherence but was only obtained in those who were randomized to receive the 
MM training after Visit 1. The association between meditation home practice time 
and outcomes was assessed using a linear regression model with the dependent 
variable being the Visit 2 – Visit 1 difference. In this analysis, only outcomes that 
were significantly affected by  MM in the above ANCOVA were evaluated.  
 
Salivary cortisol was assessed at three time points following Visit 1 and Visit 2. 
While multilevel mixed model analysis of cortisol data has been done previously 
[262, 263], we chose a simple ANCOVA analysis since there were only three 
data points. Outcomes were cortisol awakening response (CAR), the transient 
increase in cortisol for about 30 minutes after awakening, and the difference 
between the awakening cortisol minus the bedtime cortisol (slope). For the slope 
calculation, the 30 minute after awakening cortisol collection for the CAR was 
dropped as has been previously suggested [260, 263].  
 
RESULTS 
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Following telephone screenings, 134 participants came to Visit 1 and were 
randomized to receive the MM beginning shortly after Visit 1 (n=66) or to wait-list 
control in which they received the MM beginning shortly after Visit 2 (n=68) 
(Figure 1). The participant demographics (Table 3.2) were mostly women as is 
common for mind-body studies and overwhelmingly Caucasian non-Hispanic with 
under-represented minority percentages comparable to Portland metropolitan 
area statistics for this age range. Participants were also highly educated. Only 
one participant was over age 75 years old. Participants were comparable in age, 
gender, years of education or PSS at baseline between the two groups. There 
were 60 participants returning to visit 2 in the MM group compared to all 68 
participants in the wait-list group (P = 0.013). 
Table 3.2.  Participant demographics 
Variable Meditation Wait-list 
Number randomized (no. female) 66 (51)   68 (56) 
Age 60.2 + 7.4 59.4 + 6.3 
Years of Education 17.0 + 2.5 16.4 + 2.8 
Underrepresented groups (no.) 
      Hispanic 
       African American 
       Asian 
3 
1 
2 
1 
1 
4 
Perceived Stress Scale at Visit 1 19.0 + 6.1 18.5 + 6.1 
Return at Visit 2 (no.) 60 68 
74 
Figure 3.1. CONSORT figure. 
The dropout rate by Visit 2 was only 4.5% out of 134, but the dropout rate was 
higher in the MM group (Fisher’s Exact Test because of 0 dropouts in the wait-list 
group , p=0.013). The 6 dropouts had characteristics roughly comparable to the 
completers (age = 58.2 years, 4 women, education 14.5 years, and PSS  22. 
Table 3.3.   Outcome measures by group and effect size 
Outcome 
Measures 
Visit 1 
Mean (SD) 
Visit 2 
Mean (SD) 
Visit 1 
Mean (SD) 
Visit 2 
Mean (SD) 
Unadj p FDR p 
partial 
eta 
squared 
adjusted 
mean 
differ. 
Self-Rated 
NEO- N 24.8 (7.2) 20.7 (7.7) 24.4 (9.3) 23.6 (9.7) .0001 .001** .12 3.3 
PSS 18.7 (5.9) 15.2 (5.7) 18.5 (6.1) 18.5 (7.2) .0001 .001** .11 3.5 
CESD1 17.6(8.5) 12.4(7.6) 19.4(10.5) 18.5(10.9) .0002 .002** .11 4.9 
NEO-A1  33.9(4.9) 36.1(5.1) 33.5(6.3) 33.6(6.2) .0006 .003** .09 -2.2
NEO-C 28.6(7.5) 31.0(6.3) 31.1(7.1) 30.7(7.3) .0003 .002** .10 -2.3
NEO-E   24.5(4.5) 25.3(4.3) 25.3(6.4) 24.8(6.7) .03 .09 .04 -1.3
NEO-O 27.4(5.5) 28.0(5.3) 26.6(5.8) 26.5(5.1) .10 .18 .02 -0.9
PANAS-neg 
   (trait)1 
21.7(6.4) 17.9(5.5) 21.9(7.5) 20.8(7.7) .001 .005** .08 2.7
PANAS-pos1 
  (trait) 
32.1(6.3) 33.1(6.0) 32.7(7.1) 32.1(6.0) .07 .14 .03 -1.4
PANAS-neg 
  (state)1 
6.5(1.7) 6.3(1.7) 6.2(1.6) 6.3(1.5) .46 .54 .01 0.2 
PANAS-pos 
  (state)1 
14.3(3.4) 14.6(3.4) 14.5(3.3) 14.0(3.5) .21 .33 .02 -0.7
GPSE1 29.6(3.5) 30.3(3.7) 30.1(4.2) 29.2(4.0) .003 .009* .07 -1.5
Sf-36 fatigue1 39.8(19.7) 51.3(21.7) 46.5(19.4) 48.2(20.3) .002 .008* .08 8.3
SF-36 PCS1 50.4(6.5) 49.1(6.8) 50.2(6.7) 50.6(7.2) .07 .14 .03 1.6
SF-36 MCS1 37.9(9.6) 44.3(9.8) 40.0(10.6) 40.3(11.5) .00003 .001** .13 -5.7
PSQI 8.5(3.3) 6.9(3.0) 8.4(3.2) 7.6(3.0) .08 .16 .02 0.8
MAAS1 51.8(10.2) 57.6(10.1) 51.5(12.1) 54.8(11.2) .05 .14 .03 -2.6
FFMQ-NJ1  30.1(6.5) 32.9(6.0) 29.5(7.0) 30.5(7.9) .06 .14 .03 -2.0
Cognitive 
Letter Number 
   Sequencing1 
10.9(2.3) 11.5(2.7) 11.3(2.7) 11.6(2.7) .61 .69 .00 -0.2
Letter 
fluency1 dyrs) 
48.0(14.3) 46.9(13.4) 47.0(14.2) 49.5(14.2) .13 .23 .03 3.2 
Category 
  fluency 
21.4(5.9) 16.5(4.7) 21.4(5.6) 17.0(4.1) .88 .94 .00 0.6 
Stroop CW 
  condition1 
44.3(8.4) 46.4(7.6) 47.1(9.3) 49.1(7.5) .37 .48 .01 1.1 
Stroop CW 
  interference 
49.0(8.3) 48.8(7.0) 46.6(9.8) 49.5(6.8) .38 .48 .01 1.3 
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Untransformed mean (standard deviation) of outcomes at the two visits by group. For ANCOVA group effect, there are 
unadjusted (unadj.) p values, FDR adjusted p values across all outcomes, partial eta squared effect size, and adjusted 
mean difference at Visit 2 (waitlist – MM). The number of participants for most analyses is 128. For FDR p values, * 
p<.05 and ** p<.005. 
MM = mindfulness meditation intervention group; Unadj = unadjusted; FDR = False Discovery Rate; NEO =   
Neuroticism-Extraversion-Openness Personality Inventory (-N = Neuroticism; -A = Agreeableness; 
C=Conscientiousness; -E = Extraversion; -O = Openness); PSS = Perceived Stress Scale; CESD = Center for 
Word list- 
  delayed 
6.8(2.0) 7.5(1.8) 6.8(2.0) 7.3(1.9) .40 .49 .01 -0.2
Choice RT 
   (msec)1 
470(67) 462(70) 463(70) 465(59) .21 .33 .01 7.3 
Simple RT 
  (msec)1 
270(46) 267(43) 272(43) 279(40) .07 .14 .03 10.0 
  Flanker RT 
  Incongruent 
  (msec)  
753(107) 703(119) 792(165) 726(148) .37 .4 .01 -3.6
Physiological 
Respiration rate 
   1st five mins 
14.3(2.9) 13.5(3.0) 14.1(2.9) 14.2(2.7) .10 .18 .03 0.7 
Respiration rate 
   2nd five mins 
14.6(2.9) 13.7(3.1) 14.2(2.8) 14.5(2.6) .05 .09 .04 0.9 
Respiration rate 
   3rd five mins 
14.8(2.8) 13.9(3.3) 13.9(2.9) 14.8(2.8) .005 .01* .09 1.5 
CAR1 .17(.21) .13(.20) .05(.46) .12(.24) .98 .99 .00 -.01 
Cortisol slope1 -.18(.27) -.23(.14) -.26(.20) -.18(.83) .07 .14 .03 0.1 
Systolic bp  133(20) 128(20) 130(19) 128(16) .33 .44 .01 1.5 
Diastolic bp  81(13) 80(11) 80(12) 80(10) .33 .44 .01 0.5 
Heart rate 70(12) 69(12) 68(10) 68(10) .73 .80 .00 0.4 
HRV SDRR 
   (msec) 
42(21) 46(19) 41(24) 46(20) .99 .99 .00 0.0 
HRV LF/HF 
   ratio1 
1.9(1.5) 3.2(3.1) 2.5(2.1) 3.0(1.9) .29 .43 .01 -0.5
     7
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Epidemiologic Studies Depression Scale; PANAS  = Positive and Negative Affect Schedule (-neg = Negative Affect; -
pos = Positive Affect); GPSE = General Perceived Self-Efficacy; SF-36 = Short Form 36-item health-related quality of 
life; PCS = Physical Component Summary Score; MCS = Mental Component Summary Score; PSQI = Pittsburgh 
Sleep Quality Inventory; MAAS = Mindful Attention Awareness Scale; FFMQ-NJ = Five Factor Mindfulness 
Questionnaire—Non-Judgmental Factor; CW = Color Word; msec = milliseconds; RT = reaction time; mins = minutes; 
CAR = Cortisol Awakening Response; bp = blood pressure; HRV = Heart Rate Variability; SDRR = Standard Deviation 
of Inter-Beat Interval; LF = Low Frequency; HF = High Frequency.  
1 Statistical transformation was used. 
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
1.NEO-
neuroticism
1 
2.PSS .60*** 1 
3.CESD .68*** .74*** 1 
4.NEO-
agreeableness
.29** .19* .26** 1 
5.NEO-Conscient.
-.34*** -.31*** -.33*** -.19* 1 
6.NEO-
Extroversion
-.52*** -.26** -.36*** -.27** .23* 1 
7.NEO-Openness -.11 .11 .05 -.12 -.14 .19* 1 
8.PANAS-neg trait
(home)
.71*** .57*** .64*** .33*** -.23* -.29** .02 1 
9.PANAS-pos trait
(home)
-.62*** -.43*** -.48*** -.17* .44*** .63*** .15 -.40*** 1 
10.PANAS-neg
state (lab)
.24* .15 .25* .16 -.08 -.08 -.07 .32** -.08 1 
11.PANAS-pos
state (lab)
-.11 -.12 -.05 -.00 .20* .22* -.07 -.06 .38*** .16 1 
12.GPSE -.42*** -.31*** -.38*** -.18* .35*** .34*** .03 -.36*** .51*** -.21* .12 1 
13.SF-36 Fatigue -.49*** -.51*** -.53*** .05 .26** .20* -.03 -.47*** .47*** -.21* .17 .12 1 
14.SF-36 MHC -.62*** -.61*** -.64*** -.17* .31*** .28*** -.09 -.59*** .50*** -.15 .24* .11 .69*** 1 
15.SF-36 PHC .08 -.03 -.05 .04 .04 -.05 .07 -.04 -.04 -.15 -.21* .28** .12 -.30*** 1 
16.PSQI .17* .06 .18* 07 -.09 -.09 -.13 .18* -.08 .07 ..08 -.02 -.29** -.12 -.19* 1 
17.Mindfulness –
current moment
-.38*** -.34*** -.33*** -.11 .30*** .16 -.08 -.33*** .27** .08 .15 .16 .23* -.08 .36*** -.08 1 
18.Mindfulness -
non-judgemental
-.61*** -.29*** -.41*** -.26** .14 .29** .08 -.52*** .23* -.04 .08 .28** .18* -.04 .36*** -.14 .36*** 1 
Table 3.4. Correlation matrix of all normalized self-rated outcome measures, with unadjusted p values * p<.05, ** p < .005, *** p < .0005 
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Outcomes Analysis (Table 3.3) 
The outcomes related to negative affect and stress were almost all highly 
significantly improved from the MM intervention after adjusting for multiple 
comparisons. This includes CESD, PANAS-negative (trait), and PSS with small 
to moderate effect sizes (e.g., partial eta squared for CESD was 0.11). The 
PANAS-positive was not significantly affected by the MM intervention. Although 
the conventional PANAS-negative completed at home using conventional 
questions was significantly affected by MM, the state PANAS filled out in the lab 
setting demonstrated no significant change from the intervention for either 
negative or positive affect. The test-retest reliability, as assessed by the 
correlation of the measure at baseline Visit 1 with the measure at Visit 2, was 
lower than for the PANAS state version than the trait version. 
 
NEO personality traits were significantly affected by the intervention. NEO 
Neuroticism was the a priori personality trait affected (p = 0.001) but other traits 
also changed significantly, Agreeableness (p=0.003) and Conscientiousness 
(p=0.002). There was no significant change of Extraversion or Openness. 
The SF-36 Energy and Fatigue demonstrated significant improvement (p = .008). 
The calculated Mental Health Composite also demonstrated significant 
improvement (p<.0.001) but the Physical Health Composite did not. Self-efficacy 
(GPSE) also improved with the intervention. Of note, the two mindfulness 
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measures were not significantly improved although there was a trend towards 
improvement of the mindfulness-nonjudgmental factor. Subjective sleep quality 
(PSQI) was not significantly improved. See Figure 3.4 for pairwise correlations 
between all the self-rated measures. The correlations were very high for most of 
the measures that were affected by the intervention suggesting some common 
underlying factor may be assessed by all these measures. 
There were no significant intervention effects on the cognitive battery, including 
working memory (Letter Number Sequencing), Stroop test, verbal fluency 
(semantic or category), immediate or delayed verbal memory (using CERAD 
word list), flanker attention task, simple reaction time or choice reaction time. 
Additionally, there were no significant effects on salivary cortisol (awakening 
response or diurnal downward slope), heart rate, or heart rate variability. There 
was a significant decrease in respiration rate in the MM compared to waitlist 
group after 10 minutes of sitting and listening to an audio recording without 
performing any task. 
Adherence and home practice 
Participants in the MM intervention attended all one-on-one training sessions 
(these often required rescheduling) and  practiced at home an average of 30.3 
+/- 11.8 minutes per day. Using linear regression in the 60 participants who 
received MM training before Visit 2, there was no relationship between minutes 
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practiced and outcome measures that were significantly affected by the MM 
intervention compared to wait-list. 
 
DISCUSSION 
This randomized controlled trial of six-week MM training compared to waitlist 
control of 134 50-85 year olds was executed adequately, maintained blinding of 
the assessors, and had a dropout rate of only 4% through Visit 2. The six 
dropouts were disproportionately all in the MM group which may be related to the 
fact that those in the waitlist group only needed attend the Visit 2 assessment to 
receive the MM intervention and they did not need attend the six weekly training 
sessions.  
There were very significant improvements in most of the standardized, self-rated 
measures related to negative mood and stress. Of note, there was no significant 
effect for positive affect (PANAS-pos). Additionally, the assessment of stress 
using the PANAS state 10-question version was not sensitive to intervention. 
While the state version may be useful for ecological momentary assessment over 
many assessments and days, it does have more intra-subject variability. This 
may be related to the wording of the state assessment that asked “Right now I 
feel ___ ?” in contrast to the more commonly used standard version that asked 
“how you generally feel” or “how you feel on average”. 
Neuroticism was specifically analyzed as an outcome even though it correlates 
with other negative affect measures. While personality has been thought of more 
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as a stable trait measure with genetic contributions, personality as assessed with 
measures such as the NEO is affected by environmental influences and has 
been reported to change both negatively with chronic caregiver stress [30] or 
positively from a meditation intervention [264]. While Neuroticism was the most 
altered of the personality traits (decreased), Conscientiousness and 
Agreeableness also changed (increased) in response to the MM intervention; 
Extraversion and Openness did not change. 
The SF-36 health related quality of life demonstrated significant changes in the 
Mental Health Composite and Vitality subscore. The average improvement in the 
Mental Health Composite (6.4) was greater than the minimum clinically important 
difference which  is 4 [265] with the wait-list increasing by 0.3 and the average 
improvement in the Vitality subscore was 11.5, more than the minimum clinically 
important difference of about 9 [265] with the wait-list group increasing by 1.7. 
The vitality component of the SF-36 was previously improved from a mind-body 
intervention (yoga) in healthy older adults [242] and in people with multiple 
sclerosis [241].  
Self-efficacy (GPSE) improved from the intervention although less than some of 
the negative affect measures. Subjective sleep quality (PSQI) did not improve 
even though there has been suggestion of improved sleep in mind-body 
interventions [248]. Our study participants were not recruited for sleep problems 
although participants did have some sleep problems overall, with an average 
PSQI at baseline of 8.4 
83 
 
 
With the exception of respiration rate, the cognitive and physiological outcomes 
were not changed. The decline in respiration rate in the MM group was seen in 
the third 5-minute block of sitting quietly listening to auditory recordings and it 
may represent a specific training related change since awareness of breathing 
was part of the training. This finding that meditation produced benefits in 
psychological measures but not in objective physiological measures is consistent 
with some meta-analyses of meditation interventions [225, 266]. However, this 
trend in the literature contrasts with many individual MM intervention studies 
demonstrating some effect on physiological and cognitive outcomes with 
intervention lengths both longer and shorter than 6 weeks [98-105]. Due to the 
wait-list only control it could be that some benefit of the MM compared to wait-list 
may be related to simple attention and expectancy/placebo effects. The fact that 
objective measures demonstrated less change than the subjective self-rated 
measures, lends credibility to this possibility since placebo is known to have a 
greater effect on subjective measures [115, 267]. However, some of the highly 
standardized assessments such as Neuroticism are not generally known to have 
significant improvements from any intervention, let alone demonstrate a placebo 
effect. Also, the significant changes in the psychological measures were not 
correlated with expectancy.  
The lack of changes in cognitive outcomes despite the known relationships of 
cognition to chronic stress especially with aging [26, 28, 117] is of interest since it 
is known that excessive stress has a negative effect on cognitive function; thus, 
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we must question why no changes were seen with improved self-rated stress. 
The participants did not have pathological depression, PTSD, or anxiety 
disorders that are more likely to produce impairments in cognition and so our 
participants may have been performing at or near their maximal ability already. 
Over the 2-month study, perhaps the selected cognitive measures were not 
optimal even though it was a fairly broad battery with a focus on frontal/executive 
measures that are known to be more sensitive to negative affect and stress. The 
cognitive benefits of MM may be related to decreased mind-wandering [268 
Hasenkamp, 2012 #5525, 269, 270] which may not be apparent in conventional 
cognitive testing where high attentional focus is required only for relatively brief 
periods.  
There were essentially no changes in the physiological measures related to 
stress. There were no changes in HRV (LF/HF ratio and standard deviation of 
RR interval) or cortisol, which were strong theoretical candidates for sensitive 
measures. We sampled cortisol only three times a day over two days at each of 
the visits. This limitation in design was associated with poor intra-subject 
reliability for test-retest, high inter-subject coefficient of variation, and limited 
ability to calculate area under the curve or diurnal cortisol slope. Thus, the study 
design may have been at least partially responsible for the lack of significant 
change. 
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The lack of major changes in objective measures in contrast to the self-rated 
measures is likely not related only to placebo effect issues and potential 
explanations are provided.  
1) It is possible that the MM intervention was not a sufficiently long duration.  
2) The one-on-one class is likely not ideal for all participants although it has 
been quite acceptable and allows more flexibility in scheduling research 
participants. A recent survey comparing on-line, one-on-one and group 
delivery of meditation training suggested that one-on-one was at least as 
favorable as group [231]. A group setting might have produced some 
improvements because of group dynamics but group dynamics would add 
experimental noise to the intervention, and a group setting is less 
acceptable to some people, e.g., those with high introversion or PTSD.  
3) There are many physiological measures related to stress [224] which may 
increase due to a short term stressor but perhaps not decrease that much 
secondary to a longer term stress-reducing intervention. Other 
physiological changes not directly related to intracerebral processes such 
as telomerase or what have been called allostatic load measures have 
generally been more sensitive to longer term cross-sectional differences 
[141, 180-183, 212, 271] and may have similarly low sensitivity to a broad 
population intervention.  
4) The outcomes may need to be measured over a much longer time frame 
or follow-up since physiological changes related to stress improvement 
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may take considerable time (Visit 2 was at two months). For example hair 
cortisol and hippocampal size reflect stress-induced changes over a 
longer term even though they are not necessarily sensitive to acute or 
excessive transient responses [14, 166, 272].  
5) The outcomes may not be optimally chosen or well-performed. While we 
have previously demonstrated experimental and cross-sectional changes 
in cortisol and heart rate variability [153, 273], cortisol is known to have 
high test retest variability and sampling at only three time points on only 
two days may be contributing to the absence of an intervention effect.  
6.) Ecological Momentary Assessment (EMA) is different from the more 
commonly performed single assessments especially if done in in the 
laboratory environment. The laboratory induces an inherent change in 
peoples’ state, and they are not exposed to the usual environmental 
stressors that would demonstrate their negative emotional reactivity and 
coping mechanisms. This is particularly problematic for studies involving 
the effects of stress where EMA has been used [194, 195, 274, 275]. 
While the PANAS state version that would be closer to what is asked 
using EMA had more intrasubject variability, recording it many times over 
many days may actually capture reactivity to real-life stressors.  
Additionally, EMA may be preferable because assessments in the 
research lab setting may be unrealistic. For example, in a prior study of 
stressed older adults (dementia caregivers), participants  were often 
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relieved to be away from their caregiving responsibilities for the time they 
were in the laboratory and thus had lower stress in the lab compared to 
home - in contrast to control subjects who had mildly increased stress in 
lab compared to home [276].  
7.) The improvements related to meditation may primarily improve 
responsivity to stressor (resilience). The objective measures may need to 
be direct measures of resilience to stress either with experimental 
stressors or more sustained ecological momentary assessment. For 
example, cortisol on an average assessment day may be less affected 
than cortisol in response to a stressor.  
8.) It is likely that some people do not improve as a result of MM training from 
a physiological, cognitive, or even mental health perspective. It will be 
useful to better define those most likely to respond to MM training.   
9.) It is likely that different people have different physiological effects of 
stress. For example, some people may develop stress effects on their 
blood pressure, some on their gastrointestinal system, and some on their 
cognitive function.  
10.) There is no way to assess the quality of meditation so it is possible 
that the “dose” as measured in number of hours practiced was insufficient 
in this study to induce cognitive or physiological changes. 
  
As mentioned above , the optimal dose of meditation needed to induce stress-
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relieving cognitive or physiological effects is not known. Those in this MM study 
practiced an average of 28 minutes per day during the 6-week intervention as 
assessed by turning on the study iPod to listen to the guided meditation audio for 
daily practice. Among the self-rated psychological measures that did 
demonstrate improvement with MM training compared to wait-list, there was no 
relationship of the degree of improvement with minutes practiced. There is little 
empirical data to justify how long one should practice meditation to achieve 
improvements in clinically relevant markers, and it would be helpful to have better 
knowledge of the dose response effect. 
 
There are several additional limitations of this study. The age range of the study 
population was relatively narrow and participants were mostly Caucasian and 
highly educated. While participants needed to report at least mild stress, they 
were not allowed to have very significant stress attributable to conditions such as 
generalized anxiety disorder, PTSD or untreated depression. The latter 
populations may demonstrate different effects of MM on cognitive or 
physiological outcomes. 
 
This study demonstrated very significant improvement in many self-rated 
measures related to negative affect and stress, including clinically significant 
improvements in health-related quality of life and a decrease in neuroticism. 
While possible explanations for the lack of changes in cognitive and physiological 
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measures have already been discussed, there remains a need for more complex 
experimental and analytical approaches to understand the improvement in 
mental health from MM. Since reactivity to stress is a biologically complicated 
system and different people have different physiological sequelae to stress, 
researchers may well benefit from methodologies that generate more relevant 
data and take better advantage of systems science methods and approaches 
[119, 224].  
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Chapter 4.   
Predictors of improvements in mental health to mindfulness meditation 
intervention in healthy, stressed older adults using decision tree machine 
learning. 
 
 
Objective: To determine if machine learning can generate a reliable classifier to 
predict who will benefit from a mindfulness meditation (MM) intervention. 
Methods: 134 stressed 50-85 year olds were randomized to an MM intervention 
with six weekly one-on-one sessions with a trainer along with home practice or to 
a wait-list control (ClinicalTrials.gov  NCT01386060). Outcome measures were 
assessed at baseline, Visit 2, and Visit 3 (two months apart). All participants 
received the MM intervention either between baseline and Visit 2 or between 
Visit 2 and Visit 3 (wait-list). A responder was defined by comparing their 
baseline and immediate post-MM intervention data using a known minimum 
clinically important difference of the SF-36 health related quality of life mental 
health component. There were 121 participants who completed their MM training 
with baseline assessments and post-MM outcomes. Seventeen potential 
predictors included demographic information (gender, age, and years of 
education) and selected self-rated baseline measures related to stress and 
affect. Continuous predictors were normalized if necessary and all were 
standardized using the Z transformation. Simple univariate statistical analysis 
was performed to compare the values for the predictors in the responder and 
non-responder groups.  Next, nine predictors were chosen for the machine 
91 
 
 
learning analysis based on other results and a priori rationales. In addition to 
choosing nine predictors for the machine learning analysis, principal component 
analysis (PCA) was performed on all 17 baseline measures to reduce the 
number of input variables to the classifier. Classification was performed using 
decision tree analysis with 10-fold cross-validation. The reliability of the classifier 
was calculated as the mean and standard error across the classifiers. 
 
Results. 121 participants completed their MM intervention having data from 
before and after their meditation training. As defined using the SF-36 mental 
health component, there were 61 responders and 60 non-responders. Univariate 
statistical analysis of the baseline measures demonstrated significant differences 
between the responder and non-responders in several measures including the 
Positive and Negative Affect Schedule negative (PANAS-neg), SF-36 Mental 
Health Component (SF36-MHC), SF-36 Energy, the maximum PANAS-neg 
(state version) of four ecological momentary assessments  using smartphones at 
home, and Neuroticism-Extraversion-Openness (NEO) personality assessment 
of neuroticism. Decision tree analyses using 4 or 9 a priori or PCA chosen 
predictors were unable to achieve reliable classification rate of better than 65%.  
 
Discussion:  Several differences in predictor variable were observed between 
responders and non-responders to a MM intervention but decision tree analysis 
was unable to usefully predict who would respond to the intervention. Several 
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limitations to the analysis and future directions are discussed.  
 
Keywords (up to six) 
Meditation, responder, decision tree machine learning, stress, mental 
health, older adults 
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CESD – Center for Epidemiologic Studies Depression 
EMA- ecological momentary assessment 
GPSE – General Perceived Self-Efficacy 
MM – mindfulness meditation 
MHC – Mental Health Component (of the SF-36) 
NEO – Neuroticism-Extraversion-Openness 
PANAS – Positive and negative affect schedule 
PANAS-neg-max – maximum PANAS-negative of the 4 at-home EMA 
assessments 
PCA – principal component analysis 
PSQI - Pittsburgh Sleep Quality Inventory 
PSS – Perceived Stress Scale 
SF-36 – Short form 36-item health related quality of life 
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Mindfulness meditation (MM) is a popular meditation approach that has already 
been formally studied and applied in a variety of clinical conditions including 
Post-Traumatic Stress Disorder, depression, pain, and stress.[75-83] However, 
the evidence for efficacy has not been as compelling as it could be [84, 85] and 
one possible explanation may be that not everyone will improve with MM training. 
This analysis hopes to shed light on who may be most likely to benefit from MM 
training. 
 
The most evidence of benefits of MM intervention is from improvements in self-
rated stress and mental health [86, 225]. Given the complexity of the stress 
system including multiple causative factors, mediators and physiological outputs 
[224, 277, 278],  it is likely that some people benefit significantly while others may 
not benefit at all. It would be helpful to know from a clinical perspective as well as 
from a research perspective of better understanding the mechanism of MM 
benefit, what factors might predict clinically significant improvements of MM. 
Despite reported improvements following meditation interventions, there has 
been limited research into what factors predict or moderate the benefits of MM. 
At least some measures of baseline affect impact on response to meditation 
treatment. 
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This analysis was performed to determine if and which baseline assessments will 
predict who may most likely be a responder, i.e., benefit from MM training. The 
prediction analysis utilized a machine learning approach, more specifically 
decision-tree analysis [279]. 
 
METHODS.  
Participants  
Participants consisted of generally healthy adults 50-85 years of age who 
reported at least mild levels of stress. Participants were recruited from the 
greater Portland, Oregon metropolitan area. Following inquiries, participants 
were told about the study and eligibility criteria. If interested, they underwent a 
30-minute telephone inclusion screening for which there was an IRB-approved 
Waiver of Authorization. This study was approved by the Oregon Health & 
Sciences University Institutional Review Board (IRB) and was registered with 
ClinicalTrials.gov (NCT01386060). Participants provided informed consent at 
Visit 1 at the research lab. Exclusion criteria were primarily to screen out an 
underlying illness that might limit the benefit of the intervention, confound 
outcomes, or increase the likelihood of dropout (Table 4.1).  
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Table 4.1. Inclusion and exclusion criteria 
Inclusion 
Criteria 
 Age 50-85 years old;  
 Baseline Perceived Stress Scale (PSS) [228] score ≥ 9;  
 Agree to follow the study protocol including randomization; 
. 
Exclusion  
Criteria 
 Cognitive impairment (significant participant complaints) or a 
score of less < 30 on the Modified Telephone Interview for 
Cognitive Status (TICS-m) [229] 
 Significant patient-reported medical/neurologic disease (e.g., 
major organ failure; insulin-dependent diabetes, active cancer, 
or alcoholism); 
 Significant, untreated depression. Significant was defined 
based on Geriatric Depression Scale greater than 5 and 
interview; 
 Take medications known to affect CNS function or impact 
physiologic measures (e.g., steroids, neuroleptics or regular 
narcotic analgesics); stable doses of CNS-active drugs with 
less impact (e.g., beta-blockers, SSRI’s, and histamine 
blockers) were acceptable; enrolled participants were 
encouraged not to change their drug use during the study 
period and to inform the investigator if any change was made. 
 Cannot understand the instructions (e.g., cannot hear or see 
study materials or not fluent in English);  
 Prior experience with meditation classes or other mind-body 
classes (e.g., yoga or tai chi) within the last 24 months or more 
than 5 minutes daily practice in the last 30 days. 
      
 
Following Visit 1, all randomizations were performed by non-blinded research 
personnel using a computerized covariate adaptive randomization procedure 
[230] aimed at balancing active and waitlist groups on age, gender, and baseline 
Perceived Stress Scale score using a pre-determined projected median split for 
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the continuous measures. The researcher who led the meditation training 
sessions performed the randomization, and the research assistants who 
conducted data-collection visits remained blinded. There were three testing visits 
(Figure 4.1), each 2 months apart, and all participants received a 6-week MM 
training either between Visits 1 and 2 or between Visits 2 and 3 (wait-list control). 
Participants who received the intervention post-Visit 2 served as a wait-list 
control for the primary outcome analyses at Visit 2 previously described in 
chapter 3. For the definition of responder for this analysis, pre-MM intervention 
data were subtracted from the immediate post-MM data.  
 
Intervention  
The MM intervention was administered in six, one-on-one sessions occurring 
weekly either between Visit 1 and Visit 2, or between Visit 2 and Visit 3 (wait-list 
control). More details of the intervention that was a standardized and structured 
program based on Mindfulness Based Cognitive Therapy [232, 233] are 
described in Chapter 3 and a prior publication [280]. An unblinded RA delivered 
the one-on-one training sessions but the assessments were performed by 
blinded RAs. In addition to the six 60-90 minute training sessions, daily guided 
meditations for home practice were accessed with a study iPod and adherence 
tracked with developed software, iMINDr [281]. Participants were instructed to 
practice at home up to 30 minutes a day as a goal but at least do some daily 
practice. MM sessions offered strategies other than meditation for practicing 
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mindfulness skills to cope with the many stressors that adults typically face. 
Participants who were randomized to the Wait-list arm between Visit 1 and Visit 2 
received the MM intervention after the wait-list period (between Visit 2 and Visit 
3). All participants randomized to wait-list group had the same MM training in the 
Visit 2-Visit 3 period as those randomized to receive MM immediately after Visit 
1. 
 
ANALYSIS 
This is an exploratory analysis to determine if one can predict who will improve 
from MM training and, if so, which predictor variables contribute to this classifier. 
The outcome variable that demonstrated the greatest effect size in the previous 
analyses (Chapter 3) and is also moderately clinically significant was used to 
define “responder” based on their improvement immediately following MM 
training.  
 
Outcomes used to define responder 
For more detail of the outcomes, some of which are also used as predictors 
when measured at baseline, please refer to Chapter 3. Further details of the 
specific measure used to define who was a responder and predictors of being a 
responder are given below. For this analysis, a responder is someone who 
achieved a minimum clinically important difference improvement in SF-36 Mental 
Health Component which is 4 [265].  
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Predictors   
Since there were only 121 participants in this analysis, a decision was made to 
limit the machine learning analysis to only 9 predictors. One set of analyses 
utilized nine predictors chosen based on a priori hypotheses. Another set of 
analyses was performed using only nine final predictors but chosen instead 
based on principal component analysis (PCA) so all demographic and self-rated 
psychological measures could be potentially included in the analysis. A second 
set of analyses were performed with just 4 predictors in case there were 
limitations in machine learning related to overfitting or to multicollinearity of the 
input predictors. All participants who completed the MM intervention were used 
for these analyses.  
 
Demographic measures were gender, age, years of education, annual income 
and lifetime exposure to stressful events measure [282].  
 
Self-rated measures obtained at baseline Visit 1 and potentially entered into the 
predictor analysis are self-rated measures that might affect responsiveness to 
the MM intervention.   
 Stress. The Perceived Stress Scale [228] and the PANAS [236] were 
administered. At home on a Smartphone assessment tool, participants answered 
the state question PANAS [236, 238] a reduced 10-question version [239] four 
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semi-random times over waking hours, and the maximum PANAS-negative 
across the home assessments at baseline was used as a predictor. 
  Neuroticism. While neuroticism has been considered a stable trait, changes 
in neuroticism are a possible outcome from meditation studies [42, 212]. 
Neuroticism assessed with the current NEO [202] is used both as a predictor as 
well as helping to define one of the secondary responder definitions.  
 Mood.  Depression was assessed by the Center for Epidemiologic Studies 
Depression Scale (CESD) [237].  
 Fatigue.  The 4-question Energy and Fatigue subscale of the SF-36 health-
related quality of life [240] that was previously found to be sensitive to yoga in 
two  prior studies [241, 242] may be a predictor of responsiveness. 
 Self-efficacy.  A measure of self-efficacy, the General Perceived Self-Efficacy 
Scale [244], was included because of participants’ reporting their sense of control 
was significantly affected by meditation [107, 245, 246].  
 Mindfulness. A measure of mindfulness from the Five Factor Mindfulness 
Questionnaire [88] was used as a predictor. Factor 5, mindful non-judging, was 
used because it was found in prior studies to be significantly different in 
chronically stressed populations, i.e., it was different between veterans with and 
without post-traumatic stress-disorder [211] and between dementia caregivers 
and non-caregivers [30].  
 Stressful life events experienced measure was assessed with the Life 
Experiences Survey [282]. 
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 Expectancy/Credibility was assessed [250] by using the sum of the 
components. 
 
Analysis: Conventional descriptive statistics 
For descriptive purposes, the means of the 15 baseline continuous predictors 
were compared between the responders and non-responder groups using t-tests 
with unadjusted p values calculated as well as false discovery rates. Income that 
was assessed using a 7-step scale was compared using Wilcoxon rank order 
and the distribution of gender was assessed using chi-square. 
Analysis: Machine learning approach.  
Data processing was first performed in Stata 14 (StataCorp, College Station TX). 
All predictors and the outcomes to be predicted were checked for normality using 
Shapiro-Wilk and transformed if distributions were not normal (e.g., square root 
or Box-Cox to correct for skewness) even though this likely would not impact the 
decision tree analysis. The rest of the analyses were performed in Matlab 
(MathWorks, Natick, MA) including the Statistics and Machine Learning Toolbox. 
All baseline predictor measures were next standardized by dividing by the 
baseline predictor standard deviation across all the participants.  
 
The classifier used decision tree analysis for classification of responder or non-
responder as defined above. Decision tree analysis was chosen in part because 
of the small sample size, its ability to deal with missing data, and because the 
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decision tree is more interpretable to other researchers in the field as compared 
to other approaches such as support vector machine. Of note, PCA without 
rotation or other adjustment may negate the interpretability benefit. The Matlab 
function fitctree uses a greedy decision algorithm based on iterative 
dichomitization (ID3) [283] and with other enhancements or additions including 
how decisions regarding split nodes are made (e.g., information gain or Gini 
index) and pruning. The greedy ID3 algorithm, that takes the feature for the next 
node with the highest information gain, will tend to overfit so performance often 
benefits from pruning (developed in the C4.5 algorithm).  The algorithm copes 
with missing predictor values by using all available relevant data to evaluate a 
specific branch point although it cannot utilize participants with missing 
classification of responder status data.  
 
For the first set of analyses, nine predictors were chosen that had the best a 
priori rationale based on previous literature and knowledge of the predictors and 
outcome: age, years of education, stressor life events, non-judgmental 
mindfulness, Pittsburgh Sleep Quality Index, NEO-neuroticism, SF-36 Energy 
and Fatigue, Expectancy, and maximum PANAS-negative using smart-phone at 
home assessments. Since overfitting is a concern, similar analyses were 
performed with only four predictors: life events, SF-36 Energy and Fatigue, NEO-
neuroticism, and expectancy,  For the second set of analyses, dimensionality 
reduction was performed by applying PCA to all the baseline measures (17) and 
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using the participant data from the nine components with the highest variance 
explained. The full data set of 17 predictor measures with only 121 participants 
may not generate the best classifier because of overfitting and because of errors 
in decision tree learning related to multicollinearity. These issues may well occur 
with only nine predictors as well even though there would be greater than 10 
observations per predictor variable (an acceptable recommended number). Thus, 
a similar analysis was performed with just the four components with the most 
variance explained. 
 
There were several hyperparameters for the decision tree analyses that needed 
to be defined including  tree depth using maximum number of splits and minimum 
parent size as well as split criteria (maximum deviance reduction/cross-entropy 
vs Gini index). Of note, fitctree forces the minimum parent size MinParentSize) to 
be linked to minimum number of leaf node observations size (MinLeafSize), i.e., 
MinParentSize = max(MinParentSize, 2*MinLeafSize). Thus parent size cannot 
be modified independently of leaf size and the two potential parameters 
represent only one actual hyperparameter. Since there was concern about trying 
to define too many hyperparameters even before generating the decision tree 
classifier given the small data set, two parameters were defined a priori: the split 
criterion was the maximum deviance reduction and pruning was set to “on” which 
only sets the optimal sequence of pruned subtrees. Given the limited data set 
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size, the Matlab default tree definition parameters were chosen for the other 
hyperparameters.  
 
Once the hyperparameters were decided on, the model was generated using the 
full data set (n=121). The reliability of the classifier was evaluated by using a 10-
fold cross-validation and generating the mean of the classification error along 
with the standard error using the Matlab function cvloss. Since one goal was to 
help predict who will most likely benefit from MM training, the average 
information gain from the predictors in any useful classifier would be determined 
along with their mean and standard error.  
 
RESULTS 
See Figure 4.1 for the clinical trial study design with recruitment, randomization, 
and drop-out numbers. See table 4.2 for demographics and selected baseline 
measures for all participants who completed their MM training and were used for 
these analyses. Of the 121 completers, the average age was 60 years and 79% 
were women. Half were considered responders based on the SF-36 mental 
health component. The completers practiced meditation 27.0 + 10.7 mins per day 
during their intervention period.  
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Figure 4.1. Consort table. 
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Table 4.2. Demographics and predictor variables. Mean (standard deviation) 
grouped by responder status as defined by the minimum clinically important 
difference of the SF-36 MHC from the 121 participants who completed the MM 
intervention. Statistics comparing the 2 groups are given (by t for all except chi-
square for gender and Wilcoxon  rank order for 7-step income) and associated p 
values and false discovery rate adjusted p values.   
 
SF36-MHC 
responder 
n=61 
 
SF-36 MHC 
non-
responder 
n=60 
 
Statistic,  p value, 
and FDR adjusted p 
value 
 
Female (%) 51 (84%) 45 (75%)   
1.37         p=0.24 
 
0.47 
Age (years) 59.0 (6.7) 60.8 (7.1)   -1.37        p=.17 0.41 
Years of 
Education 
16.9 (2.9) 16.6 (2.4) 
 0.60         p = .55 -.62 
Income (7 
steps) 
4.6 (2.1) 4.3 (2.0) 
0.78          p = 0.43 0.53 
Life Event 
stressors 
-10.4 -6.9 
-1.58         p=0.12 0.34 
PSS 
(baseline) 
19.0 (6.1) 17.8 (5.5) 
1.07          p = 0.29 0.47 
PANAS-neg  23.2 (7.9) 19.8 (5.4) 2.77          p = 0.0065* 0.04* 
PANAS-pos 32.4 (6.9) 33.3 (6.0) -0.77         p = 0.44 0.53 
PANAS-neg-
max home 
8.6 (3.2) 7.3 (2.3) 
2.40          p = 0.018* 0.08 
NEO-
neuroticism 
25.8 (8.2) 22.8 (8.2) 
1.98          p = .05*  0.17 
CESD 18.9 (10.5) 17.0 (9.4) 1.16          p=0.25 0.47 
SF-36 MHC 36.1 (9.5) 42.7 (9.8) -3.77         p = 0.0003* 0.005* 
SF-36 Energy 38.9 (19.1) 48.9 (19.7) -3.1          p= .005* 0.03* 
GPSE 29.7 (4.2) 30.3 (3.5) -0.97        p = .33 0.47 
PSQI 8.3 (3.0) 8.3 (3.5) -0.01        p=0.99 0.99 
Mindfulness-
non-
judgmental 
29.4 (6.4) 30.5 (6.8) 
-0.97        p = 0.33 0.47 
Expectancy 28.6 (5.8) 28.3 (6.4) 0.31         p =0.75 0.80 
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MHC- mental health component of SF-36 health related quality of life;  FDR = 
False Discovery Rate; PSS = Perceived Stress Scale; PANAS  = Positive and 
Negative Affect Schedule (-neg = Negative Affect; -pos = Positive Affect); NEO = 
Neuroticism-Extraversion-Openness Personality Inventory;  CESD = Center for 
Epidemiologic Studies Depression Scale; SF-36 = Short Form health related 
quality of life; GPSE = General Perceived Self-Efficacy; SF-36 = Short Form 36-
item health-related quality of life; PSQI = Pittsburgh Sleep Quality Inventory. 
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The results from conventional univariate biostatistics are shown in Table 4.2.  
Several of the predictors were significantly different between the two groups, i.e., 
PANAS-neg, PANAS-neg-max at home, NEO-neuroticism, SF-36-mhc, and 
SF36-energy and three remained significant after correction using the false 
discovery rate: SF-36-mhc, SF-36-energy, and PANAS-neg. 
 
The hyperparameter settings of tree depth and minimum parent size had little 
effect on the overall accuracy.  
Although these settings were occasionally altered for exploratory purposes, the 
Matlab default settings were  used for final analyses. Following the definition of 
the hyperparameters, the decision tree analysis utilized the nine measures that 
were most statistically different in the responder and non-responder groups: Life 
Events, age, gender, CESD, SF36-mhc SF-36-energy, NEO-neuroticism, 
PANAS-neg, and the PANAS_neg-max at home.. The decision tree generated 
from the full data set generated a mean error rate of 0.388 using 10-fold cross-
validation with a standard error of 0.04. By altering input variables the decision 
tree was able to achieve up to a 0.347 error rate with cross-validation (standard 
error 0.04) but some decision trees still ended up with error rates of up to 0.444 
using 10-fold cross-validation with a similar standard error. Since overfitting was 
always a concern, the same analysis was also done with only 4 predictors. These 
decision tree classifier results were similar to those already described with 10-
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fold cross-validation error rates of 0.41 and standard error of 0.04 across 10-fold 
cross validation.  
 
The next step in the analysis was to use PCA to reduce the number of variables 
and try to capture the most unexplained variance. For this measure calculation 
gender was not entered and the 9 components with the highest amount of 
variance explained were chosen. The error rates were not improved (0.46 +/- 
.04). Even reducing the number of variables again, by using just the 4 
components with the most variance explained, did not produce any significant 
improvement.  
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Figure 4.2. Example of decision tree classification.  One decision tree in the 
analysis using 4 predictors yielding a 10-fold cross-validation error rate of 45%.+ 
3%. Fitctree settings were maximum number of splits = 5 and minimum parent 
size = 4. 1 is responder to MM training and 2 is a non-responder. This is level 
one pruning with one node eliminated. The 4 predictors entered in this analysis 
were Neurot = NEO-neuroticism, panasnegmx= maximum PANAS-neg from the 
4 at home ecological momentary assessments, Life Events, and expectancy,  
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DISCUSSION 
Analysis of the responders and non-responders to MM training revealed several 
significant differences in baseline measures. More specifically, those who 
improved from MM training had worse mental health prior to randomization than 
those who did not respond. The mental health measures that were different at 
baseline were the PANAS-neg, NEO-neuroticism, SF-36 Energy and Fatigue, 
and the SF-36 Mental Health Component, the latter also being what was used to 
define a responder.  Machine learning using decision tree analysis to predict 
whether or not participant’s mental health would improve following MM training 
had limited ability to correctly classify a participant as a responder or non-
responder, with accuracy rates below 70% for almost all of the analyses and 
sometimes below 60%. The baseline measures that did appear in the decision 
tree classifiers were the ones already mentioned that were different at baseline 
using univariate statistics. The only other measures that occasionally appeared in 
the classifiers were the Life Events and expectancy measures. Mindfulness (non-
judgmental), positive affect, sleep quality, and self-efficacy were also not useful 
at differentiating responder status. None of the demographic predictors including 
age, income, and gender were useful and they did not enter into the decision 
trees. Additionally, none of these latter measures were significantly different in 
responder and non-responder groups using conventional biostatistics (all p’s 
greater than 0.2). Besides the present study showing that those with worse 
mental health improve more from a meditation intervention, other studies 
described below have also observed that those with worse mental health at 
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baseline are more likely to demonstrate improvements from a meditation 
intervention.  
 
One study looking specifically at the outcome of relapse in depression, observed 
that Mindfulness-Based Cognitive Therapy was most effective in those who had 
already had three or more episodes of depression and also in those whose 
depression was not preceded by life events [284]. One study did observe an 
increased effect of meditation intervention on mental distress and well-being in 
those with higher neuroticism [285]. Personality traits have been observed to 
potentially be a factor in response to other mind-body therapies as well. 
Qualitative analysis (participant interview) suggested that some personality traits 
may predict who would respond to broader integrative medicine approach 
including yoga for asthma management [286]. One paper found those with 
greater mindfulness had greater declines in perceived stress at one year 
following the MM intervention [287]. The fact that those who responded to the 
intervention had greater fatigue at baseline is of interest. Also, of the measures 
that were different in the responder and non-responder groups, we had 
previously shown that the SF-36 Energy and Fatigue subscore was sensitive to a 
mind-body intervention in two randomized controlled trials of 6 months of yoga 
compared to control, one in a group of 69 people with multiple sclerosis [288] and 
one in a group of 135 healthy older adults.[242].  
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At least one other study also found no relationship of outcomes to baseline 
demographic factors, i.e., there was no relationship of demographics, baseline 
spirituality, or trait mindfulness on the decrease in depressive symptoms 
following MBSR [289]. Some researchers have simply determined changes in 
non-primary outcome measures, potentially at an earlier point in time than the 
final outcome measures, to see if those may predict outcome measure changes 
[113, 290], but this approach is inherently different than trying to determine 
predictors at baseline prior to the intervention. 
 
Expectancy has an impact on many outcomes, self-rated outcomes in particular 
[115, 267]. In regards to meditation, patients with cancer had greater 
improvement if they were assigned to their program preference whatever 
program they happened to be randomized to: Mindfulness-Based Cancer 
Recovery, Supportive Expressive Therapy or a stress management seminar 
[291]. Of note, the mindfulness intervention was the most preferred program, but 
those randomized to their preferred intervention improved more over time on 
quality of life regardless of actual intervention type. Women with greater 
psychological morbidity at baseline showed greater improvement in stress 
symptoms and quality of life if they received their preferred vs non-preferred 
program [291] 
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In addition to studies discussing baseline factors that relate to improvements 
from the meditation interventions, there have been previous studies of MM that 
discussed factors associated with adherence to the MM intervention. Predicting 
adherence may be important since adherence to meditation practice [292] or 
adherence to any intervention including taking placebo may correlate with better 
outcomes [115]. Most studies related to adherence to a meditation intervention 
predictor identify factors, e.g., comorbid personality disorders, associated with 
completing the intervention [113]. It is known that there are a number of other 
factors associated with adherence to mind-body interventions which may impact 
outcomes [293]. This has even been extended to fMRI activation in selected 
brain regions predicting engagement with meditation techniques [294]. 
Additionally in terms of predicting adherence, the degree of stress-related 
physiological responses did not predict amount of meditation practice time even 
though the physiological measures did respond to the meditation intervention 
[295]. Furthermore, unrealistic positive expectations have not been found to 
relate to meditation practice [296]. A larger study evaluating factors predicting 
barriers to meditation practice found no impact of age but did find an impact of 
personality trait (Conscientiousness, Neuroticism, and Openness) [297]. 
 
There were several limitations to this study. Having only a wait-list control implies 
that some benefit of the MM compared to wait-wait-list may be related to placebo 
effects [115]. If this were the case, there would be two types of response 
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contributing to the outcome analysis: 1) placebo responsiveness predicted by 
certain variables such as expectancy, and 2) responsiveness to the MM 
intervention predicted by other variables such as mental health. The number of 
observations (participants) is small for a machine learning approach even though 
the analysis limited the number of predictors to nine so that there were more than 
10 observations per variable in the training set. Decision tree analysis might have 
slightly benefited from methods such as ensemble learning or AdaBoost [298] 
methods. Additionally, decision tree analysis may not be the best machine 
learning approach for this data set [299]. Also, adding costs or penalties of 
allocation and misallocation to the decision analysis might make the analysis 
more interpretable but at this low level of classification accuracy it was not likely 
to be useful. A more general issue with predictor analysis in clinical trials is that 
responder status is subject to a “regression to the mean” effect, especially since 
many of the predictor variables are correlated to the SF-36 MHC score. Thus, 
those with lower SF-36 MHC will be more likely to improve, and many of the self-
rated predictors are correlated with the SF-36 MHC (e.g., SF-36 energy, NEO-
neuroticism, PANAS-neg). One prior study did suggest that regression to the 
mean is not the only explanation of beneficial MM effects. People with panic 
disorder receiving mindfulness-based cognitive therapy demonstrated greater 
improvements in their panic disorder symptoms if they were less depressed at 
baseline based on Hamilton Depression Rating Scale [113]. This implies that the 
responders had some relevant characteristic to predict responsiveness and, 
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given the pattern of changes, it was not simply demonstrating regression to the 
mean for people who have more extreme baseline values. Additionally, while not 
the focus of this paper, the participants in the wait-list control arm of this study 
had no major changes in their measures of stress and negative affect during the 
wait-list period (Visit 1 to Visit 2) also suggesting that regression to the mean is 
not the only issue. An additional limitation of the study is the lack of variability in 
the study sample demographics consisting of mostly highly educated women in a 
relatively narrow age range (50-85 years old) may limit both the quantitative 
analysis and the generalizability. The prevalence of women is common in mind-
body intervention studies. Broader inclusion criteria for the next study would be 
helpful. 
 
Future directions include the need to improve predictor analysis. Even though 
simple univariate analyses demonstrated that some baseline predictors were 
significantly different in the responder and non-responder groups (NEO-
neuroticism, maximum PANAS-neg at home, SF-36 Energy and Fatigue), the 
decision-tree analysis was not useful for classification. Interactions of the 
variables may need to be better captured. Machine learning is a broad field and 
other techniques may be better for this type of data [299-301]. Additionally, it is 
likely that these particular predictor variables are not capturing salient properties 
of a person vis-a-vis responding to MM intervention due to the dynamic character 
of MM. Stress reactivity rather than simply perceived stress or mental health 
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reflecting traits over some time may better capture the stress reactivity that 
participants are taught in order to decrease the non-judgmental aspect of 
mindfulness meditation training. These characteristics may need to be captured 
by more prolonged assessments using ecological momentary assessment, or 
assessing stress reactivity using experimental stressors in a lab setting. 
 
In summary, even though simple univariate statistics demonstrated some 
differences in baseline measures between responders and non-responders, 
classification accuracy using decision tree analysis was less than 70%. 
Demographic variables were particularly not useful at predicting outcomes. 
Improving the classification using other statistical or machine learning 
approaches or adding other predictor variables will be a useful future direction. 
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Chapter 5. 
Discussion 
 
The first paper in this dissertation discussed the complexity of the human stress 
system, including characterization of a stressor and the human physiology that 
responds to a stressor. There are several issues that are important especially 
from the systems science perspective that are reiterated or expanded here. 1) 
The human physiological system has many components that are altered by any 
stressor (see chapter 2, Figure 2.3). 2) The definition of a stressor event is not 
purely objective, i.e., there is no quantifiable metric of stressor severity that does 
not include individual aspects of the person since the effects of a stressor are 
highly dependent on an individual’s perception. This subjective perception is 
dependent on issues such as learning, e.g., the effects of major trauma and 
conditioning, and genes or related systems, e.g., aspects of genetics, 
epigenetics, proteomics, and metabolomics, especially as related to 
neurotransmitter function and environmental reactivity. Event perception is also 
dependent on the specific environment in which the human exists although this 
could be considered an aspect of the stressor. For example the sound of a 
gunshot in a rifle range has a different significance than the same sound heard in 
a clothing store. A transient, i.e., not sustained, stressor impacts multiple human 
physiological measures and these transient state changes are often associated 
with physiological changes that are adaptive in nature. Perhaps the most well-
known response to a stressor is the autonomic nervous system increasing heart 
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rate and blood pressure to allow for improved ability for “fight or flight”. However, 
if these responses are too sustained, then chronic hypertension or vascular 
disease may result. The cumulative or chronic effect of the changes to the 
human system resulting from repeated stressors is referred to as allostatic load 
by some [27]. Besides the more objective physiological changes, there are 
psychological changes sometimes referred to as “burnout” that have some 
degree of physiological correlates. These chronic changes to the person that 
may impact future responses to stressors can be thought of as trait changes to 
psychologists or parameter changes by systems scientists in contrast to more 
transient effects referred to as changes in state to psychologists or variables to 
systems scientists. The cost to system, i.e., the detrimental cost to the human of 
making these changes to their physiological system, depends on the magnitude 
and duration of the stressor (see Figure 2.4, Chapter 2).  
 
In general, it is important to consider the degree of the stressor and the time 
course of the stressor when thinking about how the stressor effects humans. 
Some degree of stress may be important for the human so as to maintain 
adaptability and maximize performance. In terms of maximizing performance, the 
best athletic performances are often when a race or competition is particularly 
close. In terms of maintaining adaptability, making changes in the physiological 
system in response to a moderate stressor that is not sufficient to cause 
immediate harm may be beneficial. Exposure to an intermittent low level of a 
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stressor increases future ability to compensate to a future stressor without any 
decrement in utility because of adaptive changes to the physiological system and 
such system “learning” has been called hormesis [65]. For example, exposure to 
an intermittent low level of a toxin may allow a person to tolerate what would 
normally be a lethal dose and sometimes simple learning in response to a novel 
stressor may improve ability to learn to respond to future stressors. In general, 
acute mild or moderate stressors usually do not produce long-term negative 
effects although a significantly powerful acute stressor may actually push the 
brain dynamical system into a new, functional attractor basin with lower overall 
utility. 
 
On the other hand, chronic psychological stress often produces changes in the 
system, such as a slower response to a future stressor or a higher potential for 
moving to a new lower utility attractor basin. As already mentioned, this has been 
referred to as allostatic load. Also, if a human is exposed to a “tolerable” dose of 
a stressor that results in return to the original high utility attractor basin, the 
outcome may be improved resilience. This balance between experiencing 
sufficient stressors to keep one’s physiological system adaptive or resilient 
versus experiencing declining health due to the cost of generating stressor 
responses is the reason for the inverted U-shaped effect of stress on function 
[277]. 
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From a systems science perspective, behavioral and physiological 
measurements attempting to capture the degree of stress of a system need to go 
beyond static objective measurements. One needs to incorporate the dynamics 
of the physiological stress response system as well as measures of the 
environmental stressors and their perception. Understanding stress will require 
all of the interacting components from Chapter 2 Figure 2.3 to be measured 
empirically and described, at least partially. With regard to developing useful 
models of the systems dynamics of human stress physiology, there is a paucity 
of empirical data regarding the temporal aspects of the human stress response 
because it is difficult to acquire the human data. Nevertheless, acquiring and 
analyzing dynamical data will be important to better understand stress physiology 
since the timing and strength of feedback loops likely contributes to stress-
related disorders and resilience to stressors. In addition to measuring stress 
responses over time, it may be useful to repeat administration of experimental 
stressors to better understand self-reinforcing loops. These systems science 
concepts and better measurement techniques will lead to improved 
understanding of the stress system, increased resilience of the human system, 
and better long-term health. 
 
With the knowledge of the human stress system, the third chapter describes a 
clinical experiment involving 134 at least mildly stressed older adults to evaluate 
the effects of a stress-reducing intervention on psychological and physiological 
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markers. A randomized controlled clinical trial of a mindfulness meditation (MM) 
intervention was successfully implemented with a very low dropout rate. There 
were many outcome measures and there were very significant beneficial effects 
on many self-rated measures related to negative affect, stress, and mental 
health. The effect sizes of the various outcome measures were in the small to 
medium range with partial eta squared’s ranging up to 0.13. The effect size 
reached a level above the minimal clinically important difference in the widely 
used mental health component score of the SF-36 health related quality of life 
measure.  Despite the significant changes in mental health measures, there were 
no significant changes in the objective outcome assessments (i.e., not self-rated) 
of cognition, autonomic nervous system (heart rate and heart rate variability) and 
hypothalamic-pituitary-adrenal axis (cortisol). 
 
Despite the negative findings concerning the objective measures in this study, it 
is still important to move beyond self-rated beneficial changes in stress and affect 
for two reasons. The first is to ensure that the benefits observed are not simply 
related to non-specific placebo or expectancy effects, and the second is to better 
understand the mechanism of MM benefits. Increasing our understanding the 
mechanism requires us to determine why there was a lack of changes in the 
objective measures of stress and cognition despite the significant improvements 
in self-rated measures of stress and affect. This discrepancy may relate to the 
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specifics of the particular intervention and/or outcome measurements, but also 
how one goes about assessing the stress system.  
 
In terms of the intervention, it is possible the MM intervention was not as 
powerful as it could be but that wouldn’t by itself explain the contrast in 
outcomes. Additionally, there is no way to assess the quality of meditation so it is 
possible that the meditation “dose” in this study was insufficient to induce 
cognitive or physiological changes. Of note, there was no relationship between 
simple minutes practiced and improvement in the outcome measures that did 
improve as a group. 
 
There are many physiological measures related to stress described in Chapter 2 
[224] and, while many of these may be sensitive to a short term stressor they 
may not be influenced by a longer-term stress-reducing MM intervention, MM. It 
is possible that the simple measures of autonomic nervous system and 
hypothalamic-pituitary-adrenal axis were not sufficiently sensitive. Other 
physiological changes not directly related to intracerebral processes such as 
telomerase and those referred to as allostatic load measures have mostly been 
reported to be sensitive to cross-sectional differences [141, 180-183, 212, 271] 
and may have similarly low sensitivity to an MM intervention. Assessing brain 
changes more directly in humans is possible with certain techniques, such as 
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EEG or MRI, but it is not possible to directly assess neurotransmitters as is done 
in non-human experimental subjects [278, 302]. 
 
Another possible reason for the discrepancy in outcomes may relate to the time 
course of the changes. It is possible that the intervention was not a sufficiently 
long duration. The outcomes may need to be measured over a much longer time 
frame or follow-up since physiological improvements related to stress 
improvement may not be so immediate (Visit 2 was at two months). For example, 
hair cortisol and hippocampal size reflect stress-induced changes over the long 
term but are not necessarily sensitive to acute or excessive transient responses 
[14, 166, 272]. The improvements related to meditation may primarily decrease 
responsivity to a stressor (resilience). The objective measures may need to 
measure resilience to stress either with experimental stressors or to consist of 
longer-duration assessments, e.g., using ecological momentary assessment over 
weeks or months. For example, cortisol on a typical assessment day may be less 
affected than the transient amplitude or the time course of cortisol changes in 
response to a stressor.  
 
While possible explanations for the lack of changes in cognitive and physiological 
measures have already been discussed, it is becoming evident that more 
complex experimental and analytical approaches are needed to understand the 
MM-induced improvement in mental health and reductions in stress and negative 
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affect. Since reactivity to stress is a biologically complicated system and different 
people have different physiological sequelae to stress, researchers may well 
benefit from systems science methodologies to evaluate tightly coupled data 
taking into account the temporal aspect of the stressors and the varying time 
course of resulting changes in human physiology [119, 224]. 
 
Another approach to understanding the mechanisms by which MM moderates 
stress responses in human is described in detail in Chapter 4.  In order to better 
understand the impact of stress on the human physiological system, it would be 
helpful to better understand the mechanisms of how a clinical intervention 
improves affect and perceived stress. More specifically, since MM was shown in 
Chapter 3 to improve outcome measures related to negative affect and perceived 
stress, the analysis in Chapter 4 determined what baseline personal factors 
would be able to predict the person’s responsiveness to a MM intervention.  It 
was hoped that understanding the predictors of who improved might shed light 
on the underlying mechanisms of MM benefits especially the puzzling fact that 
subjective measures improved but the objective measures did not (cognition, 
cortisol, heart rate and heart rate variability). Potential predictors for this study 
included demographic information (gender, age, income, years of education and 
exposure to life events) and selected baseline self-rated measures related to 
stress and affect. 
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The outcome chosen for the predictor analysis was the mental health component 
of the SF-36 health related quality of life measure since it had the largest effect 
size in the chapter 3 study and the adjusted mean difference compared to the 
waitlist control arm exceeded the minimum clinically important difference. 
Analysis of the responders and non-responders to MM training revealed several 
significant differences in baseline measures. More specifically, those who 
improved from MM training had worse mental health prior to randomization than 
those who did not respond. The mental health measures that were different 
between responders and non-responders at baseline were the PANAS-negative, 
NEO-neuroticism, SF-36 Energy and Fatigue, and the SF-36 Mental Health 
Component, the latter being assessed at a later visit and was also used to define 
a responder.  Machine learning using decision tree analysis to predict whether or 
not participant’s mental health would improve following MM training had limited 
ability to correctly classify a participant as a responder or non-responder, with 
accuracy rates below 70% for almost all of the analyses and often below 60%, 
little better than a coin flip. The baseline measures that did appear in the decision 
tree classifiers were the ones already mentioned that were different at baseline 
using univariate statistics. The only other measures that occasionally appeared in 
the classifiers were the Life Event and expectancy measures. Mindfulness (non-
judgmental), PANAS-positive, sleep quality, and self-efficacy were not useful at 
differentiating responder status. None of the demographic predictors including 
age, income, and gender were useful and they did not enter into the decision 
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trees. Additionally, none of these latter measures were significantly different in 
responder and non-responder groups using conventional biostatistics (all p’s 
greater than 0.2) and at least one other study also found no relationship of 
outcomes to baseline demographic factors [289]. Besides the present study 
showing that those with the lower mental health improve more from a meditation 
intervention, other studies have also observed that those with worse mental 
health at baseline are more likely to demonstrate improvements from a 
meditation intervention [284, 285]. The fact that those who responded to the 
intervention had greater fatigue at baseline is of interest. It was previously shown 
that the SF-36 Energy and Fatigue subscore was sensitive to a mind-body 
intervention in two randomized controlled trials of 6 months of yoga compared to 
control, one in a group of 69 people with multiple sclerosis [288] and one in a 
group of 135 healthy older adults.[242].  
 
Expectancy has an impact on many outcomes, especially on self-rated outcomes 
[115, 267]. Having only a wait-list control implies that some benefit of MM 
compared to wait-wait-list in this, or any study, may be related to placebo effects 
[115]. If this were the case, there would be two types of response to the MM 
intervention confounding the analysis, i.e., placebo responsiveness predicted by 
certain variables such as expectancy and responsiveness to the MM intervention 
predicted by other variables such as mental health. Regarding expectancy 
effects among patient with cancer being randomized to meditation or one of two 
other intervention groups, the mindfulness intervention was the most preferred 
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program [291]. However, those randomized to their preferred intervention 
improved more over time on quality of life regardless of actual intervention type. 
Women with greater psychological morbidity at baseline showed greater 
improvement in stress symptoms and quality of life if they received their preferred 
vs non-preferred program [291] 
 
There were several limitations to this study. From a machine learning 
perspective, the number of observations (participants) is small. To potentially 
ameliorate this concern, the analysis was limited to nine predictors so that there 
would be 10 observations per variable in the training set. Decision tree analysis 
might have slightly benefited from methods such as ensemble learning or 
AdaBoost methods [298]. Additionally, decision tree analysis may not be the best 
machine learning approach for this type of data [299]. Also, adding costs of 
allocation and misallocation to the decision analysis might make the analysis 
more interpretable but at this level of classification accuracy it was not felt to be 
worthwhile.  
 
A more general issue with predictor analysis in clinical trials is that responder 
status is in part related to regression to the mean especially since many of the 
predictor variables are correlated to the SF-36 MHC score. Thus, those with 
lower SF-36 MHC will be more likely to improve and many of the self-rated 
predictors correlate with the SF-36 MHC (e.g., SF-36 energy, NEO-neuroticism, 
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PANAS-neg). One prior study did suggest that regression to the mean is not the 
only issue .[113] as well as additional data from the dissertation study. 
Participants in the wait-list control arm of this dissertation study had no major 
changes in their measures of stress and negative affect during the wait-list period 
(Visit  1 to Visit 2) also suggesting that regression to the mean is not the only 
issue. An additional limitation of the study is the lack of variability in the study 
sample demographics consisting of mostly highly educated women in a relatively 
narrow age range (50-85 years old) may limit both the quantitative analysis as 
well as the generalizability. The prevalence of women is common in mind-body 
intervention studies. Broader inclusion criteria for the next study would be helpful. 
 
Even though simple univariate statistics demonstrated some differences in 
baseline measures between responders and non-responders, achieving a useful 
classification accuracy using decision tree analysis was not achieved. Improving 
the classification using other statistical or machine learning approaches or adding 
other predictor variables will be a useful future direction. This could potentially 
help assess interactions of the variables that may need to be better captured. 
Machine learning is a broad field [300, 301] and other machine techniques may 
be better than decision tree analysis for this data Khondoker, 2013 #6282}. 
Additionally, it is likely that these particular predictor variables were not capturing 
important dynamic properties of a person that might relate to responsiveness to 
an MM intervention. Stress reactivity rather than simply perceived stress or 
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mental health reflecting traits over some time may better capture the stress 
reactivity that one is taught to decrease in the non-judgmental aspect of 
mindfulness meditation training. These characteristics may need to be captured 
by more prolonged assessments using ecological momentary assessment, or 
assessing stress reactivity using experimental stressors in a lab setting. 
 
In summary, maintaining cognitive health with aging is an important public health 
issue given the incidence of age-related cognitive decline as well as it being of 
personal concern to most adults.  Stress is known to effect cognitive health at 
least in situations deviating from the population average such as major 
depression, post-traumatic stress disorders, and neuroticism. It is unclear if 
milder mental health problems - the target in this study - actually produce 
significant cognitive changes, and it is unclear if a stress- reducing intervention in 
such people who may be functioning close to their maximal level of performance 
would be of any benefit to their cognitive health. However, the study did 
demonstrate that self-rated mental health significantly improved from a MM 
intervention in mildly stressed older adults, adding another population to the 
evidence basis for MM.  
 
There are a number of future research directions that were pointed to by this 
study. One future research direction having a clinical implication is to define the 
threshold of stress a person is experiencing in order to better predict who may 
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benefit from an MM intervention. Another future research direction is to optimize 
the intervention itself. The MM training sessions in this study were one-on-one 
sessions adapted from the widely used and standardized Mindfulness-Based 
Cognitive Therapy. It is possible that making the intervention more easily 
available and potentially individually tailored by converting it to an internet 
delivery would be better.  
More importantly regarding the intervention itself, another future research 
direction will be to focus the intervention to foster non-reactivity to events. MM 
has two main components: focusing attention to the current moment and being 
non-judgmental. The non-judgmental component is essentially decreasing stress 
reactivity and an MM intervention focused on that aspect may be preferred. The 
other MM component, attention to the current moment may not decrease stress 
reactivity. For example, someone with PTSD who focuses on the experience of 
an increased heart rate or sense of stress when around some external 
environmental trigger will not experience improved clinical symptoms and may 
simply self-reinforce their being trapped in a non-optimal attractor basin. An 
additional research direction regarding the intervention itself would be to develop 
more objective markers for meditation quality, specifically the attention to the 
current moment or the non-judgmental/ non-reactivity to stressors. While there 
were clear and significant MM benefits in this study on self-rated measures 
related to affect, stress, and mental health, it is still unclear how these changes 
would translate into physiological effects. Thus, another future direction for 
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understanding the benefits of a stress-reducing intervention such as MM would 
be to develop better physiological markers for stress, in particular to capture the 
dynamics of the person’s response to stress, i.e., their resilience to stress. This 
could include ecological momentary assessment over longer time periods to gain 
a better understanding of the variability of the stress markers. Another approach 
to better understanding resilience to stress would be to utilize an experimental 
stressor in the lab setting.  Finally, a less well-defined but always present future 
research direction is the development of better models and better quantitative 
analysis approaches to the multivariate but dynamically limited human empirical 
data that can be practically collected.  
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